syndrome	score	normalized_score
#227810 FANCONI-BICKEL SYNDROME; FBS;;HEPATORENAL GLYCOGENOSIS WITH RENAL FANCONI SYNDROME;;HEPATIC GLYCOGENOSIS WITH FANCONI NEPHROPATHY;;HEPATIC GLYCOGENOSIS WITH AMINO ACIDURIA AND GLUCOSURIA;;FANCONI SYNDROME WITH INTESTINAL MALABSORPTION AND GALACTOSE INTOLERANCE;;PSEUDO-PHLORIZIN DIABETES;;GLYCOGENOSIS, FANCONI TYPE;;GLYCOGEN STORAGE DISEASE XI	1.1008438820000002	100.0
ALPHA-KETOGLUTARATE DEHYDROGENASE DEFICIENCY	1.02309351	92.93720269773911
TRICARBOXYLIC ACID CYCLE, DEFECT OF	1.0188679	92.55335081200914
#252011 MITOCHONDRIAL COMPLEX II DEFICIENCY;;SUCCINATE CoQ REDUCTASE DEFICIENCY	1.01871775	92.53971127579014
BARTH SYNDROME; BTHS	1.00990099	91.73880206930194
SENGERS SYNDROME	1.00900901	91.65777513945432
OCULOSKELETODENTAL SYNDROME; OCSKD	1.0041012120000001	91.21195370371328
YOU-HOOVER-FONG SYNDROME; YHFS	1.002119392	91.03192635992683
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	1.00127551	90.95526862363938
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	1.00127551	90.95526862363938
#158350 COWDEN SYNDROME 1; CWS1;;CS; CD;;MULTIPLE HAMARTOMA SYNDROME; MHAMDYSPLASTIC GANGLIOCYTOMA OF THE CEREBELLUM, INCLUDED;;CEREBELLOPARENCHYMAL DISORDER VI, INCLUDED; CPD6, INCLUDED;;CEREBELLAR GRANULE CELL HYPERTROPHY AND MEGALENCEPHALY, INCLUDED;;LHERMITTE-DUCLOS DISEASE, INCLUDED; LDD, INCLUDED;;PROTEUS-LIKE SYNDROME, INCLUDED	1.000843882	90.91605979420794
BUTYRYLCHOLINESTERASE	1.0	90.8394020579205
#145600 MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1; MHS1;;MHS;;HYPERTHERMIA OF ANESTHESIA;;HYPERPYREXIA, MALIGNANT; MHKING SYNDROME, INCLUDED;;KING-DENBOROUGH SYNDROME, INCLUDED	1.0	90.8394020579205
#602088 NEPHRONOPHTHISIS 2; NPHP2;;NPH2	1.0	90.8394020579205
#601894 GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 2; GFND2;;GLOMERULAR NEPHRITIS, FAMILIAL, WITH FIBRONECTIN DEPOSITS;;FIBRONECTIN GLOMERULOPATHY	1.0	90.8394020579205
LYMPHEDEMA AND CEREBRAL ARTERIOVENOUS ANOMALY	1.0	90.8394020579205
RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTALRETARDATION	0.958333	87.05439669237312
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.844461402	76.71036881867323
179830 RENAL TUBULAR ACIDOSIS, PROXIMAL;;RENAL TUBULAR ACIDOSIS II;;RTA, PROXIMAL TYPE;;RTA, RATE TYPE	0.5297616	48.123226977247256
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.513613692	46.65636067004094
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.509852892	46.31473184678151
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.500843882	45.496358765247685
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.500843882	45.496358765247685
GLUTATHIONE SYNTHETASE DEFICIENCY	0.5	45.41970102896025
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.5	45.41970102896025
RENAL TUBULAR ACIDOSIS III	0.5	45.41970102896025
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.5	45.41970102896025
RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA	0.40694149999999996	36.96632253255325
HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DISEASE	0.375	34.064775771720186
%236795 3-@HYDROXYISOBUTYRIC ACIDURIA	0.35073162	31.86025064360579
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.334176882	30.356428142460256
3-METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.334176882	30.356428142460256
CYSTINOSIS, NEPHROPATHIC; CTNS	0.333333	30.279770406172812
LACTIC ACIDOSIS, CHRONIC ADULT FORM	0.333333	30.279770406172812
PSEUDOHYPOALDOSTERONISM, TYPE II	0.333333	30.279770406172812
#603358 GRACILE SYNDROME;;GROWTH RETARDATION, AMINO ACIDURIA, CHOLESTASIS, IRON OVERLOAD, LACTICACIDOSIS, AND EARLY DEATH;;FINNISH LETHAL NEONATAL METABOLIC SYNDROME; FLNMS;;LACTIC ACIDOSIS, FINNISH, WITH HEPATIC HEMOSIDEROSIS;;FELLMAN SYNDROME	0.333333	30.279770406172812
#187300 TELANGIECTASIA, HEREDITARY HEMORRHAGIC, OF RENDU, OSLER, AND WEBER;HHT;;OSLER-RENDU-WEBER DISEASE;;ORW DISEASETELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 1, INCLUDED; HHT1, INCLUDED	0.291667	26.494855880027497
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 4; HHT4	0.291667	26.494855880027497
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.291667	26.494855880027497
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 6; MC3DN6	0.26755602	24.304628873797018
#602722 RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE; RTADR;;RTA, DISTAL, AUTOSOMAL RECESSIVE;;RENAL TUBULAR ACIDOSIS, AUTOSOMAL RECESSIVE, WITH PRESERVED HEARINGRENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE, WITH LATE-ONSETSENSORINEURAL HEARING LOSS, INCLUDED	0.25	22.709850514480124
ALPHA-METHYLACETOACETIC ACIDURIA	0.25	22.709850514480124
SUCCINYL-COA:3-OXOACID COA TRANSFERASE DEFICIENCY	0.25	22.709850514480124
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	0.25	22.709850514480124
%601992 FRIEDREICH ATAXIA 2; FRDA2	0.23333330000000002	21.195857452201384
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.200843882	18.24453814787154
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.2	18.1678804115841
#613370 MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 10; MODY10	0.2	18.1678804115841
229310 FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA	0.2	18.1678804115841
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.186228632	16.91689757694452
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.176057892	15.992993636857944
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.17521401	15.916335900570502
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.17521401	15.916335900570502
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2O; CMT2O	0.17410699999999998	15.815775774098363
MYOCLONUS, FAMILIAL CORTICAL; FCM	0.17410699999999998	15.815775774098363
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A	0.168786392	15.332454924793776
PETTIGREW SYNDROME	0.167510882	15.216588359074876
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.167510882	15.216588359074876
#300845 MOYAMOYA DISEASE 4 WITH SHORT STATURE, HYPERGONADOTROPIC HYPOGONADISM,AND FACIAL DYSMORPHISM; MYMY4;;CHROMOSOME XQ28 DELETION SYNDROME, 3.4-KB;;SYNDROMIC MOYAMOYA DISEASE	0.167510882	15.216588359074876
#222300 WOLFRAM SYNDROME 1; WFS1;;WFS;;DIABETES INSIPIDUS AND MELLITUS WITH OPTIC ATROPHY AND DEAFNESS; DIDMOAD	0.166667	15.139930622787437
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.166667	15.139930622787437
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.166667	15.139930622787437
SPEECH-LANGUAGE DISORDER 1	0.166667	15.139930622787437
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.166667	15.139930622787437
STORMORKEN SYNDROME; STRMK	0.166667	15.139930622787437
ARTERIAL TORTUOSITY SYNDROME	0.166667	15.139930622787437
PSEUDOHYPOALDOSTERONISM, TYPE IIE; PHA2E	0.15694149999999998	14.256472018073127
PSEUDOHYPOALDOSTERONISM, TYPE IIC	0.15694149999999998	14.256472018073127
GALACTOSEMIA	0.15694149999999998	14.256472018073127
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.154680012	14.051039800391967
#229600 FRUCTOSE INTOLERANCE, HEREDITARY;;FRUCTOSEMIA;;FRUCTOSE-1-PHOSPHATE ALDOLASE DEFICIENCY;;FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE B DEFICIENCY;;ALDOLASE B DEFICIENCY;;ALDOB DEFICIENCY	0.14763151	13.410758093307908
PYRUVATE CARBOXYLASE DEFICIENCY	0.143399902	13.026361352844395
#614491 PSEUDOHYPOALDOSTERONISM, TYPE IIB; PHA2B	0.14285699999999998	12.977044459788347
#613341 LEBER CONGENITAL AMAUROSIS 14; LCA14RETINAL DYSTROPHY, EARLY-ONSET SEVERE, LRAT-RELATED, INCLUDED;;RETINITIS PIGMENTOSA, JUVENILE, LRAT-RELATED, INCLUDED	0.14285699999999998	12.977044459788347
SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	0.14285699999999998	12.977044459788347
MYOPATHY, TUBULAR AGGREGATE, 2; TAM2	0.14285699999999998	12.977044459788347
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	0.14285699999999998	12.977044459788347
DIARRHEA 4, MALABSORPTIVE, CONGENITAL	0.14285699999999998	12.977044459788347
SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2	0.14285699999999998	12.977044459788347
#614495 PSEUDOHYPOALDOSTERONISM, TYPE IID; PHA2D;;FAMILIAL HYPERKALEMIC HYPERTENSION; FHHT	0.14285699999999998	12.977044459788347
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.13490099	12.254325268621512
OCULOECTODERMAL SYNDROME; OES	0.129101212	11.72747690303283
SAY SYNDROME	0.12627551	11.47079182295896
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4; CMH4	0.125	11.354925257240062
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.125	11.354925257240062
Fabry disease	0.125	11.354925257240062
LOWE OCULOCEREBRORENAL SYNDROME	0.125	11.354925257240062
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.123393502	11.208991939512817
GLYCEROL KINASE DEFICIENCY; GKD	0.10583748200000001	9.614213580195925
3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.10583748200000001	9.614213580195925
#243500 ISOVALERIC ACIDEMIA; IVA;;ISOVALERIC ACID CoA DEHYDROGENASE DEFICIENCY;;IVD DEFICIENCY	0.10583748200000001	9.614213580195925
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.10410121200000001	9.456491851584818
VICI SYNDROME; VICIS	0.102119392	9.27646450779839
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.10029999200000002	9.11119129969421
MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD	0.1	9.08394020579205
AMINO ACIDURIA WITH MENTAL DEFICIENCY, DWARFISM, MUSCULAR DYSTROPHY,OSTEOPOROSIS, AND ACIDOSIS	0.1	9.08394020579205
FANCONI RENOTUBULAR SYNDROME 1; FRTS1	0.1	9.08394020579205
ALAGILLE SYNDROME 1; ALGS1	0.1	9.08394020579205
TIGLIC ACIDEMIA	0.1	9.08394020579205
INTERSTITIAL LUNG AND LIVER DISEASE; ILLD	0.1	9.08394020579205
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 4	0.1	9.08394020579205
GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 1; GFND1	0.1	9.08394020579205
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.094361342	8.57172788466294
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.09175298200000001	8.334786021911142
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.09175298200000001	8.334786021911142
#614265 COMBINED MALONIC AND METHYLMALONIC ACIDURIA; CMAMMA	0.09175298200000001	8.334786021911142
DIABETES MELLITUS, KETOSIS-PRONE; KPD	0.0909091	8.2581282856237
DIABETES MELLITUS, INSULIN-DEPENDENT; IDDM	0.0909091	8.2581282856237
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.089828502	8.159967409438716
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.087632492	7.9604831741255015
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.087632492	7.9604831741255015
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.081981222	7.447125186457637
KEARNS-SAYRE SYNDROME; KSS	0.08125112	7.380803157336345
#236250 HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATEREDUCTASE ACTIVITY;;METHYLENETETRAHYDROFOLATE REDUCTASE DEFICIENCY;;MTHFR DEFICIENCYMTHFR DEFICIENCY, THERMOLABILE TYPE, INCLUDED	0.073925082	6.715310245962741
ERYTHERMALGIA, PRIMARY	0.0714995	6.494971827440285
RENAL TUBULAR ACIDOSIS, DISTAL, WITH PROGRESSIVE NERVE DEAFNESS	0.07142860000000001	6.488531313834381
RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL DOMINANT	0.07142860000000001	6.488531313834381
HYPERPARATHYROIDISM, NEONATAL SELF-LIMITED PRIMARY, WITH HYPERCALCIURIA	0.07142860000000001	6.488531313834381
#248250 HYPOMAGNESEMIA 3, RENAL; HOMG3;;HYPOMAGNESEMIA, PRIMARY, DUE TO DEFECT IN RENAL TUBULAR TRANSPORTOF MAGNESIUM;;HYPOMAGNESEMIA, ISOLATED RENAL;;HYPOMAGNESEMIA, FAMILIAL, WITH HYPERCALCIURIA AND NEPHROCALCINOSISHYPERCALCIURIA, CHILDHOOD, SELF-LIMITING, INCLUDED	0.07142860000000001	6.488531313834381
ALAGILLE SYNDROME 2	0.07142860000000001	6.488531313834381
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.07142860000000001	6.488531313834381
HYDROXYKYNURENINURIA	0.067559982	6.137108367923872
ACRORENAL-MANDIBULAR SYNDROME	0.06735983000000001	6.118926679923176
WILLIAMS-BEUREN SYNDROME; WBS	0.06516203000000001	5.919279842080278
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0573294	5.207768416339347
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.05671323	5.151795901973319
NETHERTON SYNDROME; NETH	0.053475482	4.85768080963909
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.053475482	4.85768080963909
THROMBOCYTOPENIA 1	0.0526316	4.7810230733516486
ROWLEY-ROSENBERG SYNDROME	0.0526316	4.7810230733516486
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.0526316	4.7810230733516486
PERONEUS TERTIUS MUSCLE, ABSENCE OF	0.0526316	4.7810230733516486
OSSEOUS HETEROPLASIA, PROGRESSIVE; POH	0.0526316	4.7810230733516486
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.0526316	4.7810230733516486
#116860 CEREBRAL CAVERNOUS MALFORMATIONS; CCM;;CAVERNOUS ANGIOMA, FAMILIAL;;CAVERNOUS ANGIOMATOUS MALFORMATIONS; CAM;;CEREBRAL CAPILLARY MALFORMATIONSCEREBRAL CAVERNOUS MALFORMATIONS 1, INCLUDED; CCM1, INCLUDED;;CAVERNOUS MALFORMATIONS OF CNS AND RETINA, INCLUDED;;HYPERKERATOTIC CUTANEOUS CAPILLARY-VENOUS MALFORMATIONS ASSOCIATEDWITH CEREBRAL CAPILLARY MALFORMATIONS, INCLUDED	0.0526316	4.7810230733516486
APLASIA OF EXTENSOR MUSCLES OF FINGERS, UNILATERAL, WITH GENERALIZEDPOLYNEUROPATHY	0.0526316	4.7810230733516486
#300676 MENTAL RETARDATION, X-LINKED, SYNDROMIC 14; MRXS14	0.0526316	4.7810230733516486
%153300 YELLOW NAIL SYNDROME;;YNS;;LYMPHEDEMA AND YELLOW NAILS	0.0526316	4.7810230733516486
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.0526316	4.7810230733516486
#227600 FACTOR X DEFICIENCY;;F10 DEFICIENCY;;STUART-PROWER FACTOR DEFICIENCY	0.0526316	4.7810230733516486
#604367 LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3; FPLD3;;LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH PPARG MUTATIONS	0.0526316	4.7810230733516486
CRAMPS, FAMILIAL ADOLESCENT	0.0526316	4.7810230733516486
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.049129122	4.462860066110626
AL KAISSI SYNDROME; ALKAS	0.049129122	4.462860066110626
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.045871791999999995	4.166966156605301
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.0445098	4.043243617717629
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.044461702000000006	4.038874424157448
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.044278481999999994	4.022230828912395
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.043660902	3.9661302309894655
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.04262477	3.8720086196563877
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J	0.04115099	3.7381313256914654
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 4; CEMCOX4	0.04080511	3.706711793307672
POTOCKI-LUPSKI SYNDROME	0.040580892	3.6863439642570492
SILVER-RUSSELL SYNDROME; SRS	0.039305382	3.5704773985381513
#267000 PERLMAN SYNDROME; PRLMNS;;RENAL HAMARTOMAS, NEPHROBLASTOMATOSIS, AND FETAL GIGANTISM;;NEPHROBLASTOMATOSIS, FETAL ASCITES, MACROSOMIA, AND WILMS TUMOR	0.039305382	3.5704773985381513
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.03847239	3.4948089033391203
#125310 CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTSAND LEUKOENCEPHALOPATHY; CADASIL;;DEMENTIA, HEREDITARY MULTI-INFARCT TYPE;;CASIL	0.03847239	3.4948089033391203
BETHLEM MYOPATHY 1	0.0384615	3.493819662250709
HYPOADRENOCORTICISM, FAMILIAL	0.0384615	3.493819662250709
ARTERIES, ANOMALIES OF	0.0384615	3.493819662250709
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.0384615	3.493819662250709
THUMB DEFORMITY	0.0384615	3.493819662250709
WATSON SYNDROME	0.0384615	3.493819662250709
VENULAR INSUFFICIENCY, SYSTEMIC	0.0384615	3.493819662250709
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.0384615	3.493819662250709
COWDEN SYNDROME 6; CWS6	0.0384615	3.493819662250709
#214700 DIARRHEA 1, SECRETORY CHLORIDE, CONGENITAL; DIAR1;;CHLORIDE DIARRHEA, CONGENITAL, FINNISH TYPE;;CHLORIDORRHEA, CONGENITAL	0.0384615	3.493819662250709
ATROPHODERMA VERMICULATA; AVA	0.0384615	3.493819662250709
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.0384615	3.493819662250709
HEMANGIOPERICYTOMA, MALIGNANT	0.0384615	3.493819662250709
MUSCULAR HYPERTONIA, LETHAL	0.0384615	3.493819662250709
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.0384615	3.493819662250709
#608358 MYOPATHY, MYOSIN STORAGE;;MYOPATHY, HYALINE BODY, AUTOSOMAL DOMINANT	0.0384615	3.493819662250709
%113950 BUNDLE BRANCH BLOCK, FAMILIAL ISOLATED COMPLETE RIGHT	0.0384615	3.493819662250709
PREPAPILLARY VASCULAR LOOPS	0.0384615	3.493819662250709
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.0384615	3.493819662250709
COWDEN SYNDROME 5; CWS5	0.0384615	3.493819662250709
#206920 MICROPHTHALMIA WITH LIMB ANOMALIES;;WAARDENBURG ANOPHTHALMIA SYNDROME;;ANOPHTHALMIA-SYNDACTYLY;;OPHTHALMOACROMELIC SYNDROME; OAS	0.0384615	3.493819662250709
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.038009632	3.452772243321601
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.038009631999999995	3.4527722433216
PHELAN-MCDERMID SYNDROME; PHMDS	0.037634822	3.4187247270362717
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.037434512	3.4005286864100497
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.0371353	3.373348447241495
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.037118410000000004	3.3718141697407367
CHROMOSOME 17P13.1 DELETION SYNDROME	0.036359312	3.302858161317373
SCARF SYNDROME	0.03551543	3.226200425029931
#614069 IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME2; ICF2	0.03551543	3.226200425029931
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.035493892000000006	3.2242439259884086
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.035452692	3.2205013426236215
PITT-HOPKINS SYNDROME	0.034608810000000004	3.1438436063361794
COFFIN-SIRIS SYNDROME 1; CSS1	0.034377491999999996	3.122830817530945
Glycosylphosphatidylinositol biosynthesis defect 18	0.034377491999999996	3.122830817530945
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.034377491999999996	3.122830817530945
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.034377491999999996	3.122830817530945
SPINOCEREBELLAR ATAXIA 5; SCA5	0.034177182	3.1046347769047236
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.034177182	3.1046347769047236
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.034177182	3.1046347769047236
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.034177182	3.1046347769047236
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.034177182	3.1046347769047236
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.034177182	3.1046347769047236
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.034177182	3.1046347769047236
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.034177182	3.1046347769047236
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.03361576	3.0536355381225615
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.03353361	3.046173081243503
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.03353361	3.046173081243503
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.03353361	3.046173081243503
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.03353361	3.046173081243503
#156200 MENTAL RETARDATION, AUTOSOMAL DOMINANT 1; MRD1CHROMOSOME 2q23.1 DELETION SYNDROME, INCLUDED	0.03353361	3.046173081243503
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.0333333	3.0279770406172815
MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO	0.0333333	3.0279770406172815
Adrenoleukodystrophy	0.0333333	3.0279770406172815
#302800 CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1; CMTX1;;CMTX;;CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY, X-LINKED;;HEREDITARY MOTOR AND SENSORY NEUROPATHY, X-LINKED;;HMSN, X-LINKED;;CHARCOT-MARIE-TOOTH NEUROPATHY, X-LINKED, 1;;CMT2, FORMERLY	0.0333333	3.0279770406172815
#603516 SPINOCEREBELLAR ATAXIA 10; SCA10	0.0333333	3.0279770406172815
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.0333333	3.0279770406172815
EPISODIC ATAXIA, TYPE 1; EA1	0.0333333	3.0279770406172815
#613908 SPINOCEREBELLAR ATAXIA 35; SCA35	0.0333333	3.0279770406172815
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.0333333	3.0279770406172815
#608768 SPINOCEREBELLAR ATAXIA 8; SCA8	0.0333333	3.0279770406172815
HUNTINGTON DISEASE-LIKE 1	0.0333333	3.0279770406172815
ORAL SENSIBILITY, DISTURBANCE OF	0.0333333	3.0279770406172815
SPINOCEREBELLAR ATAXIA 26	0.0333333	3.0279770406172815
#614153 SPINOCEREBELLAR ATAXIA 36; SCA36	0.0333333	3.0279770406172815
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.033184132000000005	3.0144267086911056
CHROMOSOME 5Q12 DELETION SYNDROME	0.033101981999999995	3.0069642518120467
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.033101981999999995	3.0069642518120467
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.033101981999999995	3.0069642518120467
TYSHCHENKO SYNDROME	0.033101981999999995	3.0069642518120467
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.033101981999999995	3.0069642518120467
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.033101981999999995	3.0069642518120467
#606612 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH OR WITHOUTMENTAL RETARDATION), TYPE B, 5; MDDGB5;;MUSCULAR DYSTROPHY, CONGENITAL, 1C; MDC1C;;MUSCULAR DYSTROPHY, CONGENITAL, FKRP-RELATED	0.03252551	2.954597880028914
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.03252551	2.954597880028914
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.03252551	2.954597880028914
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.032484402	2.950863653889117
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.032484401999999996	2.950863653889116
#614653 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VI; HSAN6;;HSAN VI	0.0322581	2.9303065155246046
MENTAL RETARDATION, AUTOSOMAL DOMINANT 4; MRD4	0.0322581	2.9303065155246046
FRONTOMETAPHYSEAL DYSPLASIA	0.0322581	2.9303065155246046
RAPADILINO SYNDROME	0.0322581	2.9303065155246046
SMITH-KINGSMORE SYNDROME; SKS	0.0322581	2.9303065155246046
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.0322581	2.9303065155246046
ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	0.0322581	2.9303065155246046
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.032093882	2.915389050597457
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.03125	2.8387313143100155
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.03125	2.8387313143100155
SPINOCEREBELLAR ATAXIA 37; SCA37	0.03125	2.8387313143100155
#300718 MYOPATHY, REDUCING BODY, X-LINKED, CHILDHOOD-ONSET	0.03125	2.8387313143100155
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2CC; CMT2CC	0.03125	2.8387313143100155
ATAXIA-TELANGIECTASIA-LIKE DISORDER 1; ATLD1	0.03125	2.8387313143100155
HYPEREKPLEXIA 1; HKPX1	0.03125	2.8387313143100155
MYASTHENIC SYNDROME, CONGENITAL, 23, PRESYNAPTIC; CMS23	0.03125	2.8387313143100155
MYASTHENIC SYNDROME, CONGENITAL, 15; CMS15	0.03125	2.8387313143100155
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1G; CMT1G	0.03125	2.8387313143100155
HEREDITARY MOTOR AND SENSORY NEUROPATHY V	0.03125	2.8387313143100155
MYOPATHY, MYOFIBRILLAR, 8; MFM8	0.03125	2.8387313143100155
SPASTIC ATAXIA 9, AUTOSOMAL RECESSIVE; SPAX9	0.03125	2.8387313143100155
STIFF-PERSON SYNDROME; SPS	0.03125	2.8387313143100155
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27	0.03125	2.8387313143100155
MYOPATHY, MYOFIBRILLAR, 9, WITH EARLY RESPIRATORY FAILURE; MFM9	0.03125	2.8387313143100155
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.03125	2.8387313143100155
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.03125	2.8387313143100155
NEMALINE MYOPATHY 2; NEM2	0.03125	2.8387313143100155
#611302 SPASTIC ATAXIA 2, AUTOSOMAL RECESSIVE; SPAX2	0.03125	2.8387313143100155
ATAXIA-OCULOMOTOR APRAXIA 3; AOA3	0.03125	2.8387313143100155
#160565 MYOPATHY, TUBULAR AGGREGATE, 1; TAM1;;MYOPATHY, TUBULAR AGGREGATE; TAM;;TUBULAR AGGREGATE MYOPATHY	0.03125	2.8387313143100155
SPINOCEREBELLAR ATAXIA 44; SCA44	0.03125	2.8387313143100155
NEMALINE MYOPATHY 3; NEM3	0.03125	2.8387313143100155
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5; MDDGC5	0.03125	2.8387313143100155
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.031017722000000005	2.817631319678806
KOOLEN-DE VRIES SYNDROME; KDVS	0.031017722000000005	2.817631319678806
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.030566512000000004	2.776643673076252
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.030173840000000004	2.740973583391364
#614976 CARPENTER SYNDROME 2; CRPT2	0.029742212000000004	2.701764753959908
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.029742212000000004	2.701764753959908
#305450 OPITZ-KAVEGGIA SYNDROME; OKS;;FG SYNDROME 1; FGS1;;FG SYNDROME; FGS;;MENTAL RETARDATION, LARGE HEAD, IMPERFORATE ANUS, CONGENITAL HYPOTONIA,AND PARTIAL AGENESIS OF CORPUS CALLOSUM;;KELLER SYNDROME	0.029742212000000004	2.701764753959908
#180700 ROBINOW SYNDROME, AUTOSOMAL DOMINANT; DRS;;ROBINOW DWARFISM;;FETAL FACE SYNDROME;;ACRAL DYSOSTOSIS WITH FACIAL AND GENITAL ABNORMALITIES	0.029742212000000004	2.701764753959908
#237300 CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO;;CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY;;CPS I DEFICIENCY	0.029415282	2.672066628245112
CITRULLINEMIA, CLASSIC	0.029415282	2.672066628245112
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.029415282	2.672066628245112
#311250 ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO;;ORNITHINE CARBAMOYLTRANSFERASE DEFICIENCY;;OTC DEFICIENCYVALPROATE SENSITIVITY, INCLUDED	0.029415282	2.672066628245112
#249270 THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME; TRMA;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 1 (MEGALOBLASTIC ANEMIA,DIABETES MELLITUS, AND DEAFNESS TYPE); THMD1;;MEGALOBLASTIC ANEMIA, THIAMINE-RESPONSIVE, WITH DIABETES MELLITUSAND SENSORINEURAL DEAFNESS;;ROGERS SYNDROME;;THIAMINE-RESPONSIVE ANEMIA SYNDROME;;THIAMINE-RESPONSIVE MYELODYSPLASIA	0.029415282	2.672066628245112
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.029384152	2.6692387976590486
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.029384152	2.6692387976590486
CEREBROOCULONASAL SYNDROME	0.028898330000000003	2.6251070176724656
NASODIGITOACOUSTIC SYNDROME	0.028898330000000003	2.6251070176724656
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.028898330000000003	2.6251070176724656
#276820 ULNA AND FIBULA, ABSENCE OF, WITH SEVERE LIMB DEFICIENCY;;LIMB/PELVIS-HYPOPLASIA/APLASIA SYNDROME; LPHAS;;AL-AWADI/RAAS-ROTHSCHILD SYNDROME; AARRS;;SCHINZEL PHOCOMELIA SYNDROME	0.028898330000000003	2.6251070176724656
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.028898330000000003	2.6251070176724656
ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS	0.0285714	2.5954088919576694
ATRIAL FIBRILLATION, FAMILIAL, 3; ATFB3	0.0285714	2.5954088919576694
#263400 ERYTHROCYTOSIS, FAMILIAL, 2; ECYT2;;ERYTHROCYTOSIS, AUTOSOMAL RECESSIVE BENIGN;;POLYCYTHEMIA, VHL-DEPENDENT;;POLYCYTHEMIA, CHUVASH TYPE	0.0285714	2.5954088919576694
#300049 HETEROTOPIA, PERIVENTRICULAR, X-LINKED DOMINANT;;HETEROTOPIA, FAMILIAL NODULAR;;PERIVENTRICULAR NODULAR HETEROTOPIA 1; PVNH1;;NODULAR HETEROTOPIA, BILATERAL PERIVENTRICULAR; NHBP; BPNHHETEROTOPIA, PERIVENTRICULAR NODULAR, WITH FRONTOMETAPHYSEAL DYSPLASIA,INCLUDED	0.0285714	2.5954088919576694
SICKLE CELL ANEMIA	0.0285714	2.5954088919576694
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.0285714	2.5954088919576694
%602248 MALIGNANT ATROPHIC PAPULOSIS;;DEGOS DISEASE;;PAPULOSIS, MALIGNANT ATROPHIC	0.0285714	2.5954088919576694
FIBROMUSCULAR DYSPLASIA OF ARTERIES	0.0285714	2.5954088919576694
STROKE, ISCHEMIC	0.0285714	2.5954088919576694
SNEDDON SYNDROME	0.0285714	2.5954088919576694
DERMOGRAPHISM, FAMILIAL	0.0285714	2.5954088919576694
AMYLOIDOSIS VI	0.0285714	2.5954088919576694
Polyarteritis nodosa, childhood-onset	0.0285714	2.5954088919576694
AORTIC ANEURYSM, FAMILIAL THORACIC 4	0.0285714	2.5954088919576694
#615745 ATRIAL STANDSTILL 2; ATRST2;;ATRIAL DILATION AND STANDSTILL;;CARDIOMYOPATHY, ATRIAL DILATED, WITH ATRIAL STANDSTILL	0.0285714	2.5954088919576694
ATRIAL FIBRILLATION, FAMILIAL, 1; ATFB1	0.0285714	2.5954088919576694
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.0285714	2.5954088919576694
PSEUDOXANTHOMA ELASTICUM; PXE	0.0285714	2.5954088919576694
JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME; JPHT	0.0285714	2.5954088919576694
ABDOMINAL OBESITY-METABOLIC SYNDROME 3; AOMS3	0.0285714	2.5954088919576694
WOLFF-PARKINSON-WHITE SYNDROME	0.0285714	2.5954088919576694
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.0285714	2.5954088919576694
#605714 CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED;;AMYLOIDOSIS, CEREBROARTERIAL, APP-RELATED;;AMYLOIDOSIS, HEREDITARY, WITH CEREBRAL HEMORRHAGE, DUTCH VARIANT;HCHWAD;;CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, DUTCH VARIANT;;CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, IOWA VARIANT;;CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, ITALIAN VARIANT;;CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, FLEMISH VARIANT;;CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, ARCTIC VARIANT	0.0285714	2.5954088919576694
CARDIOMYOPATHY, DILATED, 1E	0.0285714	2.5954088919576694
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.028108642	2.55337223194015
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.028108642	2.55337223194015
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.028008232	2.5442510475795146
BOHRING-OPITZ SYNDROME	0.027760392000000005	2.52173741017348
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.027760392000000005	2.52173741017348
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.027760392000000005	2.52173741017348
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.02726476	2.476714495652708
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.026916510000000005	2.445079673886038
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.026916510000000005	2.445079673886038
#608836 CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, ANTENATAL;;CPT II DEFICIENCY, LETHAL NEONATAL;;CPT2 DEFICIENCY, LETHAL NEONATAL	0.026916510000000005	2.445079673886038
COFFIN-LOWRY SYNDROME; CLS	0.026916510000000005	2.445079673886038
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.026484882000000005	2.405870844454582
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.026484882000000005	2.405870844454582
#615516 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 38; MRT38	0.026484882000000005	2.405870844454582
RAMON SYNDROME	0.025641000000000004	2.3292131081671394
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 14	0.025641000000000004	2.3292131081671394
WEILL-MARCHESANI SYNDROME 2; WMS2	0.025641000000000004	2.3292131081671394
WARBURG MICRO SYNDROME 3; WARBM3	0.025641000000000004	2.3292131081671394
250230 METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE	0.025641000000000004	2.3292131081671394
#101400 SAETHRE-CHOTZEN SYNDROME; SCS;;ACROCEPHALOSYNDACTYLY, TYPE III; ACS3;;ACS III;;CHOTZEN SYNDROME;;ACROCEPHALY, SKULL ASYMMETRY, AND MILD SYNDACTYLYSAETHRE-CHOTZEN SYNDROME WITH EYELID ANOMALIES, INCLUDED;;BLEPHAROPHIMOSIS, EPICANTHUS INVERSUS, AND PTOSIS 3, FORMERLY, INCLUDED;BPES3, FORMERLY, INCLUDED	0.025641000000000004	2.3292131081671394
#101200 APERT SYNDROME;;ACROCEPHALOSYNDACTYLY, TYPE I; ACS1;;ACS IAPERT-CROUZON DISEASE, INCLUDED;;ACROCEPHALOSYNDACTYLY, TYPE II, INCLUDED;;ACS II, INCLUDED;;VOGT CEPHALODACTYLY, INCLUDED	0.025641000000000004	2.3292131081671394
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.025641000000000004	2.3292131081671394
LETHAL CONGENITAL CONTRACTURE SYNDROME 10; LCCS10	0.025641000000000004	2.3292131081671394
PYCNODYSOSTOSIS	0.025641000000000004	2.3292131081671394
MARFAN SYNDROME; MFS	0.025641000000000004	2.3292131081671394
WEILL-MARCHESANI SYNDROME 1; WMS1	0.025641000000000004	2.3292131081671394
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.025641000000000004	2.3292131081671394
FUMARASE DEFICIENCY; FMRD	0.024750902	2.2483571380741885
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.024750902	2.2483571380741885
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.024637122	2.2380214309080384
#609060 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1; COXPD1;;HEPATOENCEPHALOPATHY, EARLY FATAL PROGRESSIVE	0.024369019999999998	2.2136672055375053
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.024369019999999998	2.2136672055375053
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.023937392	2.1744583761060494
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.023937392	2.1744583761060494
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.02379324	2.1613636946205963
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.023710942	2.1538877935100333
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.023475392	2.1324905723552905
PROPIONIC ACIDEMIA	0.023475392	2.1324905723552905
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 3; MC3DN3	0.023093509999999998	2.0978006398186073
MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE); MTDPS16	0.023093509999999998	2.0978006398186073
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.023093509999999998	2.0978006398186073
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.023093509999999998	2.0978006398186073
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5; MC3DN5	0.023093509999999998	2.0978006398186073
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.023093509999999998	2.0978006398186073
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.02294953	2.084721582710308
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.02294953	2.084721582710308
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.02294953	2.084721582710308
GRANULOMAS, CONGENITAL CEREBRAL	0.02294953	2.084721582710308
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.02294953	2.084721582710308
#557000 PEARSON MARROW-PANCREAS SYNDROME;;SIDEROBLASTIC ANEMIA WITH MARROW CELL VACUOLIZATION AND EXOCRINE PANCREATICDYSFUNCTION	0.02263151	2.0558328360678484
GLYCOGEN STORAGE DISEASE Ic; GSD1C	0.02263151	2.0558328360678484
#610773 MITOCHONDRIAL PHOSPHATE CARRIER DEFICIENCY;;MPCD	0.02263151	2.0558328360678484
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.021657232	1.9673300051096614
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.02088524	1.897202713436163
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.020837142	1.8928335198759816
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.020837142	1.8928335198759816
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.020837142	1.8928335198759816
HYPERMANGANESEMIA WITH DYSTONIA 2	0.020453612	1.8579938840047074
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.020453612	1.8579938840047074
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.020375142000000002	1.8508657161252224
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.01999326	1.8161757835885393
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.019753882	1.7944308292027187
#269921 SIALURIA;;SIALURIA, FRENCH TYPE	0.019677141999999998	1.7874598134887936
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.019675412000000003	1.787302661323234
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.019675412	1.7873026613232337
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.019675412	1.7873026613232337
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.01960973	1.7813361477172651
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.019561632	1.7769669541570832
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.019561632	1.7769669541570832
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.019561632	1.7769669541570832
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.01953126	1.7742079798377803
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.019461222	1.7678457697964476
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.019099632000000002	1.734999150406324
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.019099632000000002	1.734999150406324
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.019099632000000002	1.734999150406324
SPASTIC PSEUDOSCLEROSIS	0.0188679	1.713948754088638
MYOPATHY, CONGENITAL	0.0188679	1.713948754088638
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0188679	1.713948754088638
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0188679	1.713948754088638
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0188679	1.713948754088638
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0188679	1.713948754088638
PERONEAL NERVE, ACCESSORY DEEP	0.0188679	1.713948754088638
PALMOMENTAL REFLEX	0.0188679	1.713948754088638
CERVICAL RIB	0.0188679	1.713948754088638
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0188679	1.713948754088638
ANDROSTENONE, ABILITY TO SMELL	0.0188679	1.713948754088638
TRANSSEXUALITY	0.0188679	1.713948754088638
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0188679	1.713948754088638
#220100 CYSTINURIA;;CSNU;;CYSTINURIA, TYPE I, FORMERLY; CSNU1, FORMERLY;;CYSTINURIA, TYPE II, FORMERLY;;CYSTINURIA, TYPE III, FORMERLY; CSNU3, FORMERLY;;CYSTINURIA, TYPE NON-I, FORMERLYCYSTINURIA, TYPE A, INCLUDED;;CYSTINURIA, TYPE B, INCLUDED;;CYSTINURIA, TYPE A/B, INCLUDED	0.0188679	1.713948754088638
MOTION SICKNESS	0.0188679	1.713948754088638
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0188679	1.713948754088638
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0188679	1.713948754088638
THUMBS, CONGENITAL CLASPED	0.0188679	1.713948754088638
DIASTEMATOMYELIA	0.0188679	1.713948754088638
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0188679	1.713948754088638
#610189 SENIOR-LOKEN SYNDROME 6; SLSN6	0.0188679	1.713948754088638
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0188679	1.713948754088638
COGNITIVE FUNCTION 1, SOCIAL	0.0188679	1.713948754088638
#601277 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A; ARCI4A;;ICHTHYOSIS CONGENITA IIB; ICR2B;;ICHTHYOSIS, LAMELLAR, 2, FORMERLY; LI2, FORMERLY	0.0188679	1.713948754088638
269800 SENILE PLAQUE FORMATION	0.0188679	1.713948754088638
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0188679	1.713948754088638
SPATIAL VISUALIZATION, APTITUDE FOR	0.0188679	1.713948754088638
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0188679	1.713948754088638
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0188679	1.713948754088638
RHEUMATOID ARTHRITIS	0.0188679	1.713948754088638
CARDIAC ARRHYTHMIA	0.0188679	1.713948754088638
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0188679	1.713948754088638
141405 HEMIFACIAL SPASM, FAMILIAL	0.0188679	1.713948754088638
ALCOHOL DEPENDENCE	0.0188679	1.713948754088638
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0188679	1.713948754088638
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0188679	1.713948754088638
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0188679	1.713948754088638
ENDOCARDIAL FIBROELASTOSIS	0.0188679	1.713948754088638
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0188679	1.713948754088638
NOVELTY SEEKING PERSONALITY TRAIT	0.0188679	1.713948754088638
MERALGIA PARAESTHETICA, FAMILIAL	0.0188679	1.713948754088638
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0188679	1.713948754088638
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0188679	1.713948754088638
JUMPING FRENCHMAN OF MAINE	0.0188679	1.713948754088638
#259420 OSTEOGENESIS IMPERFECTA, TYPE III;;OI, TYPE III;;OI3;;OSTEOGENESIS IMPERFECTA, PROGRESSIVELY DEFORMING, WITH NORMAL SCLERAE	0.0188679	1.713948754088638
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	0.01883153	1.7106449250357914
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.01883153	1.7106449250357914
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.01883153	1.7106449250357914
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.018399902000000003	1.6714360956043357
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.018399902000000003	1.6714360956043357
LEIGH SYNDROME; LS	0.018399902000000003	1.6714360956043357
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.018399902000000003	1.6714360956043357
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.018399902000000003	1.6714360956043357
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.018399902000000003	1.6714360956043357
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.018399902000000003	1.6714360956043357
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.018399902	1.6714360956043353
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 1; CEMCOX1	0.018399902	1.6714360956043353
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.018399902	1.6714360956043353
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.018399902	1.6714360956043353
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.018399902	1.6714360956043353
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.018399902	1.6714360956043353
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.01825575	1.6583414141188821
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.01755602	1.5947783593168932
#613561 MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 2; MLASA2	0.01755602	1.5947783593168932
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.01755602	1.5947783593168932
LIVER FAILURE, INFANTILE, TRANSIENT	0.01755602	1.5947783593168932
#500009 MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT; MMIT;;MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT, DUE TO RESPIRATORY CHAINDEFICIENCY;;COX DEFICIENCY MYOPATHY, INFANTILE, TRANSIENT;;RESPIRATORY CHAIN DEFICIENCY, INFANTILE, TRANSIENT	0.01755602	1.5947783593168932
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.01755602	1.5947783593168932
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8	0.01755602	1.5947783593168932
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.01755602	1.5947783593168932
MYOPATHY WITH EXERCISE INTOLERANCE, SWEDISH TYPE	0.01755602	1.5947783593168932
#614096 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 8; COXPD8;;CARDIOMYOPATHY, HYPERTROPHIC MITOCHONDRIAL, FATAL INFANTILE	0.01755602	1.5947783593168932
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.01755602	1.5947783593168932
CHROMOSOME 3pter-p25 DELETION SYNDROME	0.016871022	1.532553550586022
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.016871022	1.532553550586022
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.016871022	1.532553550586022
DESBUQUOIS DYSPLASIA 2; DBQD2	0.016871022	1.532553550586022
CHROMOSOME 1P36 DELETION SYNDROME	0.016871022	1.532553550586022
BARATELA-SCOTT SYNDROME	0.016871022	1.532553550586022
#220120 D-GLYCERIC ACIDURIA;;D-GLYCERIC ACIDEMIA;;GLYCERATE KINASE DEFICIENCY	0.016203892	1.4719518602911215
3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY; HMGCLD	0.016203892	1.4719518602911215
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC	0.016203892	1.4719518602911215
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.016102012000000002	1.4626971420094608
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.01602714	1.4558958142985796
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.01602714	1.4558958142985796
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.01602714	1.4558958142985796
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.015595511999999999	1.4166869848671235
WIEDEMANN-STEINER SYNDROME; WDSTS	0.015595511999999999	1.4166869848671235
#616351 MENTAL RETARDATION, AUTOSOMAL DOMINANT 34; MRD34	0.015595511999999999	1.4166869848671235
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.015595511999999999	1.4166869848671235
EPILEPSY-TELANGIECTASIA	0.015575929999999998	1.4149081676960253
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.015085462000000001	1.3703543478474816
WITTEVEEN-KOLK SYNDROME	0.015085462000000001	1.3703543478474816
ASPARTYLGLUCOSAMINURIA; AGU	0.01506588	1.3685755306763832
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.014928382	1.3560852945722233
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.014928382	1.3560852945722233
METHYLMALONIC ACIDURIA, CBLB TYPE	0.014928382	1.3560852945722233
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.014928382	1.3560852945722233
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.014928382	1.3560852945722233
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.014928382	1.3560852945722233
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.014928382	1.3560852945722233
METHYLMALONIC ACIDURIA, CBLA TYPE	0.014928382	1.3560852945722233
LICHTENSTEIN SYNDROME	0.014751629999999998	1.3400292485796816
#102500 HAJDU-CHENEY SYNDROME; HJCYS;;ACROOSTEOLYSIS WITH OSTEOPOROSIS AND CHANGES IN SKULL AND MANDIBLE;;CHENEY SYNDROME;;ARTHRODENTOOSTEODYSPLASIA;;SERPENTINE FIBULA-POLYCYSTIC KIDNEY SYNDROME; SFPKS	0.014751629999999998	1.3400292485796816
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.014634252	1.329366701244927
#251120 METHYLMALONYL-CoA EPIMERASE DEFICIENCY;;METHYLMALONYL-CoA RACEMASE DEFICIENCY;;METHYLMALONIC ACIDURIA III, FORMERLYMETHYLMALONYL-CoA EPIMERASE DEFICIENCY WITH SEPIAPTERIN REDUCTASEDEFICIENCY, INCLUDED	0.0140845	1.2794275582847812
HYPEROXALURIA, PRIMARY, TYPE I; HP1	0.0140845	1.2794275582847812
#222748 DIHYDROPYRIMIDINASE DEFICIENCY;;DIHYDROPYRIMIDINURIA;;DPYS DEFICIENCY;;DPH DEFICIENCY	0.0140845	1.2794275582847812
DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR10	0.0140845	1.2794275582847812
#613677 HYPERALDOSTERONISM, FAMILIAL, TYPE III;;FH III	0.0140845	1.2794275582847812
HAWKINSINURIA	0.0140845	1.2794275582847812
MEDIUM CHAIN 3-KETOACYL-COA THIOLASE DEFICIENCY	0.0140845	1.2794275582847812
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.0140845	1.2794275582847812
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.0140845	1.2794275582847812
#177735 PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL DOMINANT; PHA1A;;PHA I, AUTOSOMAL DOMINANT	0.0140845	1.2794275582847812
RIBOFLAVIN DEFICIENCY	0.0140845	1.2794275582847812
SUDDEN CARDIAC FAILURE, INFANTILE	0.0140845	1.2794275582847812
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.0140845	1.2794275582847812
#615605 FANCONI RENOTUBULAR SYNDROME 3; FRTS3	0.0140845	1.2794275582847812
#264350 PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B;;PHA I, AUTOSOMAL RECESSIVE	0.0140845	1.2794275582847812
LACTASE DEFICIENCY, CONGENITAL	0.0140845	1.2794275582847812
GLUTARIC ACIDEMIA I; GA1	0.0140845	1.2794275582847812
GLUCOSE/GALACTOSE MALABSORPTION; GGM	0.0140845	1.2794275582847812
COHEN-GIBSON SYNDROME; COGIS	0.014002202000000002	1.2719516571742187
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.013982620000000001	1.2701728400031203
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.013982620000000001	1.2701728400031203
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.013982620000000001	1.2701728400031203
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.013809952	1.2544877821285831
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.013613692	1.2366596410806958
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.013613692	1.2366596410806958
ALAZAMI-YUAN SYNDROME	0.013613692	1.2366596410806958
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.013613692	1.2366596410806958
#300004 CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA;;ACC WITH ABNORMAL GENITALIA;;PROUD SYNDROME	0.013613692	1.2366596410806958
GOLDBERG-SHPRINTZEN SYNDROME	0.013613692	1.2366596410806958
#614701 CORNELIA DE LANGE SYNDROME 4; CDLS4	0.013613692	1.2366596410806958
HOLOPROSENCEPHALY 5; HPE5	0.013613692	1.2366596410806958
#615541 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 39; MRT39	0.013613692	1.2366596410806958
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.013613692	1.2366596410806958
HOLOPROSENCEPHALY 11	0.013613692	1.2366596410806958
MOEBIUS SYNDROME; MBS	0.013158320000000001	1.1952939208867763
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.01296607	1.1778300458411413
9q subtelomeric deletion syndrome	0.01276981	1.1600019047932535
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.01276981	1.1600019047932535
CORNELIA DE LANGE SYNDROME 1	0.01276981	1.1600019047932535
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.01276981	1.1600019047932535
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.01276981	1.1600019047932535
#148820 WAARDENBURG SYNDROME, TYPE 3; WS3;;WAARDENBURG SYNDROME WITH UPPER LIMB ANOMALIES;;WAARDENBURG SYNDROME, TYPE III;;KLEIN-WAARDENBURG SYNDROME	0.01276981	1.1600019047932535
FONTAINE PROGEROID SYNDROME; FPS	0.01276981	1.1600019047932535
#190440 TRIGONOCEPHALY 1; TRIGNO1;;CRANIOSYNOSTOSIS, METOPIC	0.01276981	1.1600019047932535
KLEEFSTRA SYNDROME	0.01276981	1.1600019047932535
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.01276981	1.1600019047932535
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.012338182	1.1207930753617974
CORNELIA DE LANGE SYNDROME 3	0.012338182	1.1207930753617974
ELSAHY-WATERS SYNDROME; ESWS	0.012338182	1.1207930753617974
DESANTO-SHINAWI SYNDROME	0.012338182	1.1207930753617974
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.012338182	1.1207930753617974
Temtamy preaxial brachydactyly syndrome	0.012338182	1.1207930753617974
EVEN-PLUS SYNDROME	0.012338182	1.1207930753617974
SMITH-MAGENIS SYNDROME; SMS	0.012338182	1.1207930753617974
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.012338182	1.1207930753617974
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.012338182	1.1207930753617974
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.012338182	1.1207930753617974
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.012338182	1.1207930753617974
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.012338182	1.1207930753617974
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.012338182	1.1207930753617974
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.012338182	1.1207930753617974
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.012020382000000001	1.0919243133877905
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.011828132000000002	1.0744604383421554
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.011828132000000002	1.0744604383421554
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.011828132000000002	1.0744604383421554
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.011828132000000002	1.0744604383421554
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.011828132000000002	1.0744604383421554
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.011828132000000002	1.0744604383421554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.011828132000000002	1.0744604383421554
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.011828132000000002	1.0744604383421554
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.011828132000000002	1.0744604383421554
AICARDI-GOUTIERES SYNDROME 7	0.011828132000000002	1.0744604383421554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.011828132000000002	1.0744604383421554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.011828132000000002	1.0744604383421554
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.011828132000000002	1.0744604383421554
AICARDI-GOUTIERES SYNDROME 6	0.011828132000000002	1.0744604383421554
#252940 MUCOPOLYSACCHARIDOSIS, TYPE IIID; MPS3D;;MPS IIID;;SANFILIPPO SYNDROME D;;N-ACETYLGLUCOSAMINE-6-SULFATASE DEFICIENCY	0.011494299999999999	1.0441353390743555
#193510 WAARDENBURG SYNDROME, TYPE 2A; WS2A;;WAARDENBURG SYNDROME, TYPE IIA;;WAARDENBURG SYNDROME WITHOUT DYSTOPIA CANTHORUM;;WS2	0.011494299999999999	1.0441353390743555
WAARDENBURG SYNDROME, TYPE 1; WS1	0.011494299999999999	1.0441353390743555
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.011494299999999999	1.0441353390743555
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.011494299999999999	1.0441353390743555
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.011494299999999999	1.0441353390743555
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.011494299999999999	1.0441353390743555
MARSHALL-SMITH SYNDROME; MRSHSS	0.011494299999999999	1.0441353390743555
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.011494299999999999	1.0441353390743555
#300143 MENTAL RETARDATION, X-LINKED 21; MRX21;;MENTAL RETARDATION, X-LINKED 34; MRX34	0.011494299999999999	1.0441353390743555
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.011494299999999999	1.0441353390743555
CHROMOSOME 15q13.3 MICRODELETION SYNDROME	0.011494299999999999	1.0441353390743555
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.011494299999999999	1.0441353390743555
MCDONOUGH SYNDROME	0.011494299999999999	1.0441353390743555
TRANSALDOLASE DEFICIENCY	0.011494299999999999	1.0441353390743555
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.011494299999999999	1.0441353390743555
MENTAL RETARDATION, X-LINKED 97; MRX97	0.011494299999999999	1.0441353390743555
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.011494299999999999	1.0441353390743555
MENTAL RETARDATION, X-LINKED 73	0.011494299999999999	1.0441353390743555
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.011494299999999999	1.0441353390743555
#300860 MENTAL RETARDATION, X-LINKED, SYNDROMIC, NASCIMENTO TYPE; MRXSN;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 30; MRXS30	0.011494299999999999	1.0441353390743555
ZIMMERMANN-LABAND SYNDROME 1	0.011494299999999999	1.0441353390743555
PRIMROSE SYNDROME; PRIMS	0.011494299999999999	1.0441353390743555
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.011494299999999999	1.0441353390743555
#252930 MUCOPOLYSACCHARIDOSIS TYPE IIIC;;MPS IIIC; MPS3C;;SANFILIPPO SYNDROME C;;ACETYL-CoA:ALPHA-GLUCOSAMINIDE N-ACETYLTRANSFERASE DEFICIENCY	0.011494299999999999	1.0441353390743555
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.011494299999999999	1.0441353390743555
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.011494299999999999	1.0441353390743555
AMAUROSIS CONGENITA, CONE-ROD TYPE, WITH CONGENITAL HYPERTRICHOSIS	0.011494299999999999	1.0441353390743555
COCKAYNE SYNDROME A; CSA	0.0111765	1.0152665771003484
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.0111765	1.0152665771003484
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.0111765	1.0152665771003484
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.0111765	1.0152665771003484
MENTAL RETARDATION, X-LINKED 12; MRX12	0.0111765	1.0152665771003484
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.011128402	1.0108973835401667
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.011128402	1.0108973835401667
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.010984250000000001	0.9978027020547132
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.010984250000000001	0.9978027020547132
JOUBERT SYNDROME 24	0.010744872	0.9760577476688924
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.010744872	0.9760577476688924
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.010744872	0.9760577476688924
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.010744872	0.9760577476688924
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.010744872	0.9760577476688924
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.010744872	0.9760577476688924
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.010744872	0.9760577476688924
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.010744872	0.9760577476688924
HYDROCEPHALUS, NORMAL-PRESSURE	0.010744872	0.9760577476688924
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.010744872	0.9760577476688924
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.010744872	0.9760577476688924
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.010744872	0.9760577476688924
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.010744872	0.9760577476688924
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.010666402000000002	0.9689295797894074
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.010666402000000002	0.9689295797894074
INFANTILE LIVER FAILURE SYNDROME 1	0.010666402000000002	0.9689295797894074
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.010666402000000002	0.9689295797894074
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.010552622000000001	0.9585938726232571
SCHINDLER DISEASE, TYPE I	0.010552622000000001	0.9585938726232571
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.010552622000000001	0.9585938726232571
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.010552622000000001	0.9585938726232571
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.010552622000000001	0.9585938726232571
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.010552622000000001	0.9585938726232571
#300672 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2; EIEE2;;INFANTILE SPASM SYNDROME, X-LINKED 2; ISSX2	0.010552622000000001	0.9585938726232571
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.010552622000000001	0.9585938726232571
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.010552622000000001	0.9585938726232571
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.010552622000000001	0.9585938726232571
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.010552622000000001	0.9585938726232571
#615369 EPILEPTIC ENCEPHALOPATHY, CHILDHOOD-ONSET; EEOC	0.010552622000000001	0.9585938726232571
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.010552622000000001	0.9585938726232571
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.010552622000000001	0.9585938726232571
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.010552622000000001	0.9585938726232571
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.010552622000000001	0.9585938726232571
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.010552622000000001	0.9585938726232571
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.010552622000000001	0.9585938726232571
ZTTK SYNDROME; ZTTKS	0.010552622000000001	0.9585938726232571
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.010552622000000001	0.9585938726232571
#226750 KOHLSCHUTTER-TONZ SYNDROME; KTZS;;EPILEPSY AND YELLOW TEETH;;EPILEPSY, DEMENTIA, AND AMELOGENESIS IMPERFECTA;;KOHLSCHUTTER SYNDROME	0.010552622000000001	0.9585938726232571
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.010552622000000001	0.9585938726232571
#609161 STRIATAL DEGENERATION, AUTOSOMAL DOMINANT; ADSD	0.00990099	0.8994000113814503
KUFOR-RAKEB SYNDROME	0.00990099	0.8994000113814503
NEMALINE MYOPATHY 6	0.00990099	0.8994000113814503
EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3	0.00990099	0.8994000113814503
MAST SYNDROME	0.00990099	0.8994000113814503
MYOCLONIC EPILEPSY OF LAFORA	0.00990099	0.8994000113814503
SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT; SPG80	0.00990099	0.8994000113814503
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.00990099	0.8994000113814503
NONAKA MYOPATHY	0.00990099	0.8994000113814503
%300158 ARTHROGRYPOSIS, CONGENITAL, LOWER LIMB, X-LINKED; ACLLX;;ARTHROGRYPOSIS, X-LINKED, TYPE V, FORMERLY; AMCX5, FORMERLY	0.00990099	0.8994000113814503
#214500 CHEDIAK-HIGASHI SYNDROME; CHS	0.00990099	0.8994000113814503
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.00990099	0.8994000113814503
#600116 PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE; PARK2;;PARKINSON DISEASE, JUVENILE, AUTOSOMAL RECESSIVE; PDJ;;PARKINSONISM, EARLY-ONSET, WITH DIURNAL FLUCTUATION; EPDF	0.00990099	0.8994000113814503
BEHR SYNDROME	0.00990099	0.8994000113814503
#601455 CHARCOT-MARIE-TOOTH DISEASE, TYPE 4D; CMT4D;;NEUROPATHY, HEREDITARY MOTOR AND SENSORY, LOM TYPE; HMSNL;;CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, AUTOSOMAL RECESSIVE, TYPE4D;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 4D;;HMSN4D	0.00990099	0.8994000113814503
SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE; SPG43	0.00990099	0.8994000113814503
#118700 CHOREA, BENIGN HEREDITARY; BHC;;BCH;;HEREDITARY PROGRESSIVE CHOREA WITHOUT DEMENTIA	0.00990099	0.8994000113814503
NEMALINE MYOPATHY 7; NEM7	0.00990099	0.8994000113814503
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.00990099	0.8994000113814503
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.00990099	0.8994000113814503
METACHROMATIC LEUKODYSTROPHY	0.00990099	0.8994000113814503
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.00990099	0.8994000113814503
TREMOR, HEREDITARY ESSENTIAL, AND IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS	0.00990099	0.8994000113814503
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.00990099	0.8994000113814503
BRITTLE CORNEA SYNDROME 2; BCS2	0.00990099	0.8994000113814503
#164300 OCULOPHARYNGEAL MUSCULAR DYSTROPHY; OPMD;;MUSCULAR DYSTROPHY, OCULOPHARYNGEAL	0.00990099	0.8994000113814503
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.00990099	0.8994000113814503
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.00990099	0.8994000113814503
DYSTONIA 23; DYT23	0.00990099	0.8994000113814503
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.00990099	0.8994000113814503
#615156 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS,AUTOSOMAL DOMINANT, 6; PEOA6;;PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL DOMINANT, 6	0.00990099	0.8994000113814503
MYOPATHY, DISTAL, 1; MPD1	0.00990099	0.8994000113814503
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE; CMT2EE	0.00990099	0.8994000113814503
DYSTONIA 16; DYT16	0.00990099	0.8994000113814503
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 5	0.00990099	0.8994000113814503
%271630 BRACHYOLMIA TYPE 1, TOLEDO TYPE;;SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, TOLEDO TYPE;;SED, CHONDROITIN SULFATE TYPE;;PAPS-CHONDROITIN SULFATE SULFOTRANSFERASE DEFICIENCY	0.00990099	0.8994000113814503
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1	0.00990099	0.8994000113814503
#608030 AMYOTROPHIC LATERAL SCLEROSIS 6, WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA;ALS6AMYOTROPHIC LATERAL SCLEROSIS 6, AUTOSOMAL RECESSIVE, INCLUDED	0.00990099	0.8994000113814503
#612020 SPASTIC PARAPLEGIA 39, AUTOSOMAL RECESSIVE; SPG39;;NTE-RELATED MOTOR NEURON DISORDER; NTEMND	0.00990099	0.8994000113814503
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.00990099	0.8994000113814503
MYASTHENIC SYNDROME, CONGENITAL, 7, PRESYNAPTIC; CMS7	0.00990099	0.8994000113814503
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00990099	0.8994000113814503
MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16	0.00990099	0.8994000113814503
#156550 KNIEST DYSPLASIA	0.00990099	0.8994000113814503
MELNICK-NEEDLES SYNDROME	0.00990099	0.8994000113814503
TRYPTOPHANURIA WITH DWARFISM	0.00990099	0.8994000113814503
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.00990099	0.8994000113814503
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, OKINAWA TYPE; HMSNO	0.00990099	0.8994000113814503
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4; LGMDD4	0.00990099	0.8994000113814503
ALZHEIMER DISEASE 3; AD	0.00990099	0.8994000113814503
224550 DYSTONIA WITH RINGBINDEN	0.00990099	0.8994000113814503
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.00990099	0.8994000113814503
#230600 GM1-GANGLIOSIDOSIS, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, JUVENILE TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 2GANGLIOSIDOSIS, GENERALIZED GM1, LATE-INFANTILE TYPE, INCLUDED	0.00990099	0.8994000113814503
TENORIO SYNDROME; TNORS	0.00990099	0.8994000113814503
CHOREOATHETOSIS, FAMILIAL INVERTED	0.00990099	0.8994000113814503
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22	0.00990099	0.8994000113814503
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.00990099	0.8994000113814503
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.00990099	0.8994000113814503
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.00990099	0.8994000113814503
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.009852892	0.8950308178212685
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.009852892	0.8950308178212685
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.009852892	0.8950308178212685
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.009852892	0.8950308178212685
#614582 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9; COXPD9	0.009852892	0.8950308178212685
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.009852892	0.8950308178212685
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.009852892	0.8950308178212685
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.009852892	0.8950308178212685
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.009852892	0.8950308178212685
MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY; ECHS1D	0.009852892	0.8950308178212685
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.009852892	0.8950308178212685
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.009852892	0.8950308178212685
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.009852892	0.8950308178212685
PSEUDO-TORCH SYNDROME 2	0.009822520000000001	0.8922718435019653
ALANINURIA WITH MICROCEPHALY, DWARFISM, ENAMEL HYPOPLASIA, AND DIABETES MELLITUS	0.009822520000000001	0.8922718435019653
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.009822520000000001	0.8922718435019653
RETT SYNDROME; RTT	0.00970874	0.881936136335815
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.00970874	0.881936136335815
#271930 STRIATONIGRAL DEGENERATION, INFANTILE; SNDI;;INFANTILE BILATERAL STRIATAL NECROSIS; IBSN;;BILATERAL STRIATAL NECROSIS, INFANTILE;;STRIATAL DEGENERATION, FAMILIAL	0.00970874	0.881936136335815
KRABBE DISEASE	0.00970874	0.881936136335815
ALEXANDER DISEASE	0.00970874	0.881936136335815
HAMAMY SYNDROME; HMMS	0.00970874	0.881936136335815
CANAVAN DISEASE	0.00970874	0.881936136335815
BIRK-LANDAU-PEREZ SYNDROME; BILAPES	0.00970874	0.881936136335815
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.00970874	0.881936136335815
#256731 CEROID LIPOFUSCINOSIS, NEURONAL, 5; CLN5;;CEROID LIPOFUSCINOSIS, NEURONAL, 5, VARIABLE AGE AT ONSETNEURONAL CEROID LIPOFUSCINOSIS, LATE INFANTILE, FINNISH VARIANT, INCLUDED;;FINNISH vLINCL, INCLUDED	0.00970874	0.881936136335815
RETT SYNDROME, CONGENITAL VARIANT	0.00970874	0.881936136335815
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.00970874	0.881936136335815
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00970874	0.881936136335815
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.00970874	0.881936136335815
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.00970874	0.881936136335815
#236792 L-2-HYDROXYGLUTARIC ACIDURIA;;L-2-HYDROXYGLUTARIC ACIDEMIA	0.00970874	0.881936136335815
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.00970874	0.881936136335815
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.00970874	0.881936136335815
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.00970874	0.881936136335815
STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET	0.00970874	0.881936136335815
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.00970874	0.881936136335815
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.00970874	0.881936136335815
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.00970874	0.881936136335815
#264470 PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY;;STRAIGHT-CHAIN ACYL-CoA OXIDASE DEFICIENCY;;PSEUDONEONATAL ADRENOLEUKODYSTROPHY	0.00970874	0.881936136335815
DYSOSTEOSCLEROSIS	0.00970874	0.881936136335815
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.00970874	0.881936136335815
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.009458352	0.8591910401333364
BARAITSER-WINTER SYNDROME 1; BRWS1	0.009458352	0.8591910401333364
CHROMOSOME 10Q26 DELETION SYNDROME	0.009458352	0.8591910401333364
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.009390892000000001	0.8530630140705092
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.009390892000000001	0.8530630140705092
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.009390892000000001	0.8530630140705092
HYPOTONIA-CYSTINURIA SYNDROME	0.009390892000000001	0.8530630140705092
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.009390892000000001	0.8530630140705092
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.009390892000000001	0.8530630140705092
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.009390892000000001	0.8530630140705092
NAVAJO NEUROHEPATOPATHY	0.009390892000000001	0.8530630140705092
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.009390892000000001	0.8530630140705092
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.009390892000000001	0.8530630140705092
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.009390892000000001	0.8530630140705092
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.009390892000000001	0.8530630140705092
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.009390892000000001	0.8530630140705092
#245400 MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITHMETHYLMALONIC ACIDURIA); MTDPS9;;LACTIC ACIDOSIS, FATAL INFANTILE, FORMERLY	0.009390892000000001	0.8530630140705092
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.009390892000000001	0.8530630140705092
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.009390892000000001	0.8530630140705092
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 24; MC1DN24	0.00900901	0.8183730815338263
#614651 COENZYME Q10 DEFICIENCY, PRIMARY, 2; COQ10D2	0.00900901	0.8183730815338263
GLYCOGEN STORAGE DISEASE 0, LIVER	0.00900901	0.8183730815338263
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.00900901	0.8183730815338263
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.00900901	0.8183730815338263
#274150 THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL; TTP;;MICROANGIOPATHIC HEMOLYTIC ANEMIA;;THROMBOTIC MICROANGIOPATHY, FAMILIAL;;UPSHAW-SCHULMAN SYNDROME; USS;;SCHULMAN-UPSHAW SYNDROME;;UPSHAW FACTOR, DEFICIENCY OF;;MICROANGIOPATHIC HEMOLYTIC ANEMIA, CONGENITAL;;THROMBOTIC THROMBOCYTOPENIC PURPURA, FAMILIAL	0.00900901	0.8183730815338263
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.00900901	0.8183730815338263
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.00900901	0.8183730815338263
LYSINURIC PROTEIN INTOLERANCE; LPI	0.00900901	0.8183730815338263
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 3	0.00900901	0.8183730815338263
LEBER OPTIC ATROPHY AND DYSTONIA	0.00900901	0.8183730815338263
GLYCOGEN STORAGE DISEASE XI; GSD11	0.00900901	0.8183730815338263
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.00900901	0.8183730815338263
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00900901	0.8183730815338263
PERRAULT SYNDROME 5; PRLTS5	0.00900901	0.8183730815338263
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.00900901	0.8183730815338263
#614652 COENZYME Q10 DEFICIENCY, PRIMARY, 3; COQ10D3	0.00900901	0.8183730815338263
#615395 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 16; COXPD16	0.00900901	0.8183730815338263
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.00900901	0.8183730815338263
MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT; IMMD	0.00900901	0.8183730815338263
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 29; MC1DN29	0.00900901	0.8183730815338263
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.00900901	0.8183730815338263
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.00900901	0.8183730815338263
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.008614469999999999	0.7825333038458943
#300337 HYPOMELANOSIS OF ITO; HMI;;INCONTINENTIA PIGMENTI ACHROMIANS; IPA;;ITO HYPOMELANOSIS; ITO;;INCONTINENTIA PIGMENTI, TYPE I, FORMERLY; IP1, FORMERLY	0.008614469999999999	0.7825333038458943
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.00854701	0.7764052777830671
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.00854701	0.7764052777830671
#615595 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 19; COXPD19	0.00854701	0.7764052777830671
GLYCOGEN STORAGE DISEASE IB	0.00854701	0.7764052777830671
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.00854701	0.7764052777830671
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.00854701	0.7764052777830671
GLYCOGEN STORAGE DISEASE IA	0.00854701	0.7764052777830671
#614111 PYRUVATE DEHYDROGENASE E1-BETA DEFICIENCY; PDHBD	0.00854701	0.7764052777830671
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 3	0.00854701	0.7764052777830671
MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A	0.00854701	0.7764052777830671
SUCCINIC ACIDEMIA	0.00854701	0.7764052777830671
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 2	0.00854701	0.7764052777830671
#615418 MITOCHONDRIAL DNA DEPLETION SYNDROME 12 (CARDIOMYOPATHIC TYPE); MTDPS12	0.00854701	0.7764052777830671
#614053 MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 3;MC5DN3;;MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, ATP5E TYPE	0.00854701	0.7764052777830671
MYOPATHY, MITOCHONDRIAL, LETHAL INFANTILE	0.00854701	0.7764052777830671
#607196 MICROCEPHALY, AMISH TYPE; MCPHA;;AMISH LETHAL MICROCEPHALY;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 3 (MICROCEPHALY TYPE); THMD3	0.00854701	0.7764052777830671
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.00854701	0.7764052777830671
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.00854701	0.7764052777830671
PHENFORMIN 4-HYDROXYLATION	0.00854701	0.7764052777830671
MAPLE SYRUP URINE DISEASE; MSUD	0.00854701	0.7764052777830671
207720 APNEA, CENTRAL SLEEP;;SLEEP APNEA, LETHAL CENTRAL	0.00854701	0.7764052777830671
GLYCOGEN STORAGE DISEASE IXC	0.00854701	0.7764052777830671
#309548 MENTAL RETARDATION, X-LINKED, ASSOCIATED WITH FRAGILE SITE FRAXE;;FRAXE MENTAL RETARDATION SYNDROME	0.00733896	0.6666667381269962
EHLERS-DANLOS SYNDROME, TYPE VI	0.00733896	0.6666667381269962
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc; CDG2C	0.0062010220000000005	0.5632971306280103
EMANUEL SYNDROME	0.0062010220000000005	0.5632971306280103
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.006201022	0.5632971306280102
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.0053767220000000004	0.4884182115116664
HADZISELIMOVIC SYNDROME	0.0053767220000000004	0.4884182115116664
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.0053767220000000004	0.4884182115116664
C SYNDROME	0.0053767220000000004	0.4884182115116664
#602398 DESMOSTEROLOSIS	0.0053767220000000004	0.4884182115116664
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.0053767220000000004	0.4884182115116664
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.0053767220000000004	0.4884182115116664
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.0053767220000000004	0.4884182115116664
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.0053767220000000004	0.4884182115116664
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.0053767220000000004	0.4884182115116664
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.0053767220000000004	0.4884182115116664
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.0053767220000000004	0.4884182115116664
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.0053767220000000004	0.4884182115116664
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.0053767220000000004	0.4884182115116664
#300831 CK SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH THIN BODY HABITUS AND CORTICALMALFORMATION	0.0053767220000000004	0.4884182115116664
HARTSFIELD SYNDROME; HRTFDS	0.0053767220000000004	0.4884182115116664
Congenital disorder of glycosylation, type IIh	0.0053767220000000004	0.4884182115116664
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.0053767220000000004	0.4884182115116664
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id; CDG1D	0.0053767220000000004	0.4884182115116664
#300867 KABUKI SYNDROME 2; KABUK2	0.0053767220000000004	0.4884182115116664
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.0053767220000000004	0.4884182115116664
#194190 WOLF-HIRSCHHORN SYNDROME; WHS;;CHROMOSOME 4p16.3 DELETION SYNDROME;;PITT-ROGERS-DANKS SYNDROME; PRDS;;PITT SYNDROME	0.0053767220000000004	0.4884182115116664
WARSAW BREAKAGE SYNDROME; WABS	0.0053767220000000004	0.4884182115116664
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.0053767220000000004	0.4884182115116664
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.0053767220000000004	0.4884182115116664
CHROMOSOME 14q11-q22 DELETION SYNDROME	0.0053767220000000004	0.4884182115116664
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.0053767220000000004	0.4884182115116664
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.0053767220000000004	0.4884182115116664
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.0053767220000000004	0.4884182115116664
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.0053767220000000004	0.4884182115116664
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.0053767220000000004	0.4884182115116664
Mental retardation, autosomal dominant 21	0.0053767220000000004	0.4884182115116664
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.0053767220000000004	0.4884182115116664
OGDEN SYNDROME; OGDNS	0.0053767220000000004	0.4884182115116664
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl; CDG2L	0.0053767220000000004	0.4884182115116664
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.0053767220000000004	0.4884182115116664
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.0053767220000000004	0.4884182115116664
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.0053767220000000004	0.4884182115116664
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.0053767220000000004	0.4884182115116664
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.005376722	0.48841821151166637
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.005376722	0.48841821151166637
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.005376722	0.48841821151166637
RING CHROMOSOME 14 SYNDROME	0.005376722	0.48841821151166637
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.005376722	0.48841821151166637
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.005376722	0.48841821151166637
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.005376722	0.48841821151166637
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.005376722	0.48841821151166637
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.005376722	0.48841821151166637
#610127 CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10;;CEROID LIPOFUSCINOSIS, NEURONAL, CATHEPSIN D-DEFICIENT;;NEURONAL CEROID LIPOFUSCINOSIS DUE TO CATHEPSIN D DEFICIENCYNEURONAL CEROID LIPOFUSCINOSIS, CONGENITAL, INCLUDED	0.00535714	0.4866393943405682
#215100 RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1; RCDP1;;PEROXISOME BIOGENESIS DISORDER 9; PBD9;;CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC FORM; CDPR;;CHONDRODYSTROPHIA CALCIFICANS PUNCTATA	0.00535714	0.4866393943405682
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.00535714	0.4866393943405682
CARDIAC LIPIDOSIS, FAMILIAL	0.00535714	0.4866393943405682
#608747 INSULIN-LIKE GROWTH FACTOR I DEFICIENCY;;IGF1 DEFICIENCY;;GROWTH RETARDATION WITH SENSORINEURAL DEAFNESS AND MENTAL RETARDATION	0.00535714	0.4866393943405682
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.00535714	0.4866393943405682
XYLOSIDASE DEFICIENCY	0.00535714	0.4866393943405682
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.00535714	0.4866393943405682
#309801 MICROPHTHALMIA, SYNDROMIC 7; MCOPS7;;MICROPHTHALMIA WITH LINEAR SKIN DEFECTS; MLS;;MICROPHTHALMIA, DERMAL APLASIA, AND SCLEROCORNEA;;MIDAS SYNDROME	0.00535714	0.4866393943405682
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00535714	0.4866393943405682
EPILEPSY, PYRIDOXINE-DEPENDENT	0.004925512	0.4474305649091121
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.004925512	0.4474305649091121
#170100 PROLIDASE DEFICIENCY	0.004925512	0.4474305649091121
SALLA DISEASE	0.004925512	0.4474305649091121
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.004925512	0.4474305649091121
#606777 GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1;;GLUCOSE TRANSPORT DEFECT, BLOOD-BRAIN BARRIERGLUT1 DEFICIENCY SYNDROME 1, AUTOSOMAL RECESSIVE, INCLUDED	0.004925512	0.4474305649091121
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.004925512	0.4474305649091121
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.004925512	0.4474305649091121
LARSEN-LIKE SYNDROME	0.004925512	0.4474305649091121
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.004925512	0.4474305649091121
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.004925512	0.4474305649091121
REVESZ SYNDROME	0.004925512	0.4474305649091121
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.00453284	0.41176047522422426
#257300 MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1; MVA1;;MVA SYNDROME	0.00453284	0.41176047522422426
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.00453284	0.41176047522422426
MARTSOLF SYNDROME	0.00453284	0.41176047522422426
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.00453284	0.41176047522422426
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.00453284	0.41176047522422426
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.00453284	0.41176047522422426
OCULODENTODIGITAL DYSPLASIA; ODDD	0.00453284	0.41176047522422426
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00453284	0.41176047522422426
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.00453284	0.41176047522422426
RENPENNING SYNDROME 1; RENS1	0.00453284	0.41176047522422426
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.00453284	0.41176047522422426
CRI-DU-CHAT SYNDROME	0.00453284	0.41176047522422426
DUBOWITZ SYNDROME	0.00453284	0.41176047522422426
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00453284	0.41176047522422426
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.00453284	0.41176047522422426
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.00453284	0.41176047522422426
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00453284	0.41176047522422426
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.00453284	0.41176047522422426
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00453284	0.41176047522422426
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.00453284	0.41176047522422426
COFFIN-SIRIS SYNDROME 10; CSS10	0.00453284	0.41176047522422426
JACOBSEN SYNDROME	0.00453284	0.41176047522422426
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.00453284	0.41176047522422426
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00453284	0.41176047522422426
Diamond-Blackfan anemia 1	0.00453284	0.41176047522422426
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.00453284	0.41176047522422426
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.00453284	0.41176047522422426
FEINGOLD SYNDROME 1; FGLDS1	0.00453284	0.41176047522422426
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.00453284	0.41176047522422426
#610832 FANCONI ANEMIA, COMPLEMENTATION GROUP N; FANCN	0.00453284	0.41176047522422426
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.00453284	0.41176047522422426
MARDEN-WALKER SYNDROME	0.00453284	0.41176047522422426
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.00453284	0.41176047522422426
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.00453284	0.41176047522422426
CHROMOSOME 18Q DELETION SYNDROME	0.00453284	0.41176047522422426
#278250 WRINKLY SKIN SYNDROME; WSS	0.00453284	0.41176047522422426
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.00453284	0.41176047522422426
OROFACIODIGITAL SYNDROME I; OFD1	0.00453284	0.41176047522422426
LATHOSTEROLOSIS	0.00453284	0.41176047522422426
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.004101212	0.3725516457927682
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.004101212	0.3725516457927682
OROFACIODIGITAL SYNDROME VI	0.004101212	0.3725516457927682
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.004101212	0.3725516457927682
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.004101212	0.3725516457927682
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.004101212	0.3725516457927682
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.004101212	0.3725516457927682
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.004101212	0.3725516457927682
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.004101212	0.3725516457927682
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.004101212	0.3725516457927682
WEAVER SYNDROME	0.004101212	0.3725516457927682
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.004101212	0.3725516457927682
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.004101212	0.3725516457927682
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.004101212	0.3725516457927682
#252500 MUCOLIPIDOSIS II ALPHA/BETA;;MUCOLIPIDOSIS II; ML II;;ML II ALPHA/BETA;;I-CELL DISEASE; ICD	0.004101212	0.3725516457927682
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.004101212	0.3725516457927682
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.004101212	0.3725516457927682
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.004101212	0.3725516457927682
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.004101212	0.3725516457927682
CHROMOSOME 16Q22 DELETION SYNDROME	0.004101212	0.3725516457927682
COSTELLO SYNDROME; CSTLO	0.004101212	0.3725516457927682
TEMPLE-BARAITSER SYNDROME; TMBTS	0.004101212	0.3725516457927682
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.004101212	0.3725516457927682
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.004101212	0.3725516457927682
#613603 CHROMOSOME 4q32.1-q32.2 TRIPLICATION SYNDROME	0.004101212	0.3725516457927682
FRONTOOCULAR SYNDROME	0.004101212	0.3725516457927682
JOUBERT SYNDROME 10	0.004101212	0.3725516457927682
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.004101212	0.3725516457927682
BAKER-GORDON SYNDROME; BAGOS	0.004101212	0.3725516457927682
DIAPHANOSPONDYLODYSOSTOSIS	0.004101212	0.3725516457927682
NOONAN SYNDROME 6; NS6	0.004101212	0.3725516457927682
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.004101212	0.3725516457927682
XQ25 DUPLICATION SYNDROME	0.004101212	0.3725516457927682
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.004101212	0.3725516457927682
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.004101212	0.3725516457927682
NOONAN SYNDROME 3; NS3	0.004101212	0.3725516457927682
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.004101212	0.3725516457927682
JOUBERT SYNDROME 1	0.004101212	0.3725516457927682
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.004101212	0.3725516457927682
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.004101212	0.3725516457927682
PEHO-LIKE SYNDROME; PEHOL	0.004101212	0.3725516457927682
CHROMOSOME 9P DELETION SYNDROME	0.004101212	0.3725516457927682
PEHO SYNDROME; PEHO	0.004101212	0.3725516457927682
LYMPHEDEMA, HEREDITARY, III	0.004101212	0.3725516457927682
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.004101212	0.3725516457927682
NOONAN SYNDROME 5; NS5	0.004101212	0.3725516457927682
COFFIN-SIRIS SYNDROME 6; CSS6	0.004101212	0.3725516457927682
INFANTILE SIALIC ACID STORAGE DISEASE	0.004101212	0.3725516457927682
THAUVIN-ROBINET-FAIVRE SYNDROME	0.004101212	0.3725516457927682
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.004101212	0.3725516457927682
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.004101212	0.3725516457927682
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.004101212	0.3725516457927682
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.004101212	0.3725516457927682
LAMB-SHAFFER SYNDROME	0.004101212	0.3725516457927682
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.004101212	0.3725516457927682
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.004101212	0.3725516457927682
JOUBERT SYNDROME 14	0.004101212	0.3725516457927682
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.004101212	0.3725516457927682
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.004101212	0.3725516457927682
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.004101212	0.3725516457927682
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.004101212	0.3725516457927682
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.004101212	0.3725516457927682
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.004101212	0.3725516457927682
MENTAL RETARDATION, X-LINKED 91; MRX91	0.004101212	0.3725516457927682
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.004101212	0.3725516457927682
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.004101212	0.3725516457927682
PHAGOCYTOSIS, PLASMA-RELATED DEFECT IN	0.00408163	0.37077282862167005
SODIUM-POTASSIUM-ATPASE ACTIVITY OF RED CELL	0.00408163	0.37077282862167005
SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	0.00408163	0.37077282862167005
FETAL IODINE DEFICIENCY DISORDER	0.00408163	0.37077282862167005
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.00408163	0.37077282862167005
600333 MOTOR NEURON DISEASE WITH DEMENTIA AND OPHTHALMOPLEGIA	0.00408163	0.37077282862167005
PENDRED SYNDROME	0.00408163	0.37077282862167005
OSTEOGENIC SARCOMA	0.00408163	0.37077282862167005
PACMAN DYSPLASIA	0.00408163	0.37077282862167005
BLOOD GROUP, DUFFY SYSTEM; FY	0.00408163	0.37077282862167005
#270300 PEELING SKIN SYNDROME 1; PSS1;;PSS;;SKIN PEELING, FAMILIAL CONTINUOUS GENERALIZED;;KERATOLYSIS EXFOLIATIVA CONGENITA;;DECIDUOUS SKIN	0.00408163	0.37077282862167005
ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE	0.00408163	0.37077282862167005
%257600 OCULAR MYOPATHY WITH CURARE SENSITIVITY	0.00408163	0.37077282862167005
SPONDYLOEPIPHYSEAL DYSPLASIA WITH PUNCTATE CORNEAL DYSTROPHY	0.00408163	0.37077282862167005
MYASTHENIA, CONGENITAL, REFRACTORY TO ACETYLCHOLINESTERASE INHIBITORS	0.00408163	0.37077282862167005
TESTICULAR GERM CELL TUMOR; TGCT	0.00408163	0.37077282862167005
PREMATURE CENTROMERE DIVISION; PCD	0.00408163	0.37077282862167005
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.00408163	0.37077282862167005
103230 ADRENOCORTICAL HYPOFUNCTION, CHRONIC PRIMARY CONGENITAL;;ADDISON DISEASE, CONGENITAL	0.00408163	0.37077282862167005
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2A	0.00408163	0.37077282862167005
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, ASSOCIATED WITH ABNORMALITY OF REDCELL MEMBRANE	0.00408163	0.37077282862167005
#225250 HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 5; CHNG5	0.00408163	0.37077282862167005
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.00408163	0.37077282862167005
CITRULLINE TRANSPORT DEFECT	0.00408163	0.37077282862167005
PREMATURE OVARIAN FAILURE 1	0.00408163	0.37077282862167005
PSEUDOCHOLINESTERASE, INCREASE IN PLASMA LEVEL OF	0.00408163	0.37077282862167005
THYROID CANCER, NONMEDULLARY, 2; NMTC2	0.00408163	0.37077282862167005
SERTOLI CELL-ONLY SYNDROME	0.00408163	0.37077282862167005
MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS	0.00408163	0.37077282862167005
DERMATOLEUKODYSTROPHY	0.00408163	0.37077282862167005
PLATELET PROSTACYCLIN RECEPTOR DEFECT	0.00408163	0.37077282862167005
LYMPHOBLASTIC TRANSFORMATION, INTRINSIC DEFECT IN	0.00408163	0.37077282862167005
MAGNESIUM, ELEVATED RED CELL	0.00408163	0.37077282862167005
%193090 TRANSCOBALAMIN I DEFICIENCY;;TCN1 DEFICIENCY;;COBALAMIN PSEUDODEFICIENCY DUE TO TRANSCOBALAMIN DEFICIENCY;;COBALAMIN R BINDER PROTEIN DEFICIENCYTRANSCOBALAMIN I DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED;;R BINDER DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED	0.00408163	0.37077282862167005
POLYCYSTIC OVARY SYNDROME 1	0.00408163	0.37077282862167005
PSEUDOURIDINURIA AND MENTAL DEFECT	0.00408163	0.37077282862167005
GONADOBLASTOMA	0.00408163	0.37077282862167005
#121300 COPROPORPHYRIA, HEREDITARY; HCP;;COPROPORPHYRINOGEN OXIDASE DEFICIENCY;;CPOX DEFICIENCY;;CPO DEFICIENCY;;CPX DEFICIENCYHARDEROPORPHYRIA, INCLUDED	0.00408163	0.37077282862167005
ALPHA-2-DEFICIENT COLLAGEN DISEASE	0.00408163	0.37077282862167005
GAPO SYNDROME; GAPOS	0.00408163	0.37077282862167005
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.00408163	0.37077282862167005
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIx;;CDG-x	0.00408163	0.37077282862167005
#301830 SPINAL MUSCULAR ATROPHY, X-LINKED 2; SMAX2;;SPINAL MUSCULAR ATROPHY, X-LINKED LETHAL INFANTILE;;SPINAL MUSCULAR ATROPHY, INFANTILE X-LINKED; XLSMA;;ARTHROGRYPOSIS MULTIPLEX CONGENITA, DISTAL, X-LINKED;;AMC, DISTAL, X-LINKED;;ARTHROGRYPOSIS, X-LINKED, TYPE I; AMCX1	0.00408163	0.37077282862167005
CALVARIAL HYPEROSTOSIS	0.00408163	0.37077282862167005
CATECHOL-O-METHYLTRANSFERASE	0.00408163	0.37077282862167005
AREDYLD	0.00408163	0.37077282862167005
TRISOMY 18-LIKE SYNDROME	0.00408163	0.37077282862167005
MACULAR DYSTROPHY, CORNEAL, 1	0.00408163	0.37077282862167005
VENTRICULAR TACHYCARDIA, FAMILIAL	0.00408163	0.37077282862167005
#185020 CRYOHYDROCYTOSIS; CHC;;STOMATOCYTOSIS, COLD-SENSITIVE	0.00408163	0.37077282862167005
CONE-ROD DYSTROPHY 1; CORD1	0.00408163	0.37077282862167005
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.00408163	0.37077282862167005
VASCULITIS, LYMPHOCYTIC, NODULAR	0.00408163	0.37077282862167005
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.00408163	0.37077282862167005
MYELOPEROXIDASE DEFICIENCY	0.00408163	0.37077282862167005
245650 LARSEN-LIKE SYNDROME, LETHAL TYPE	0.00408163	0.37077282862167005
LACTOSE INTOLERANCE, ADULT TYPE	0.00408163	0.37077282862167005
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.00408163	0.37077282862167005
MYOPATHY, SPHEROID BODY	0.00408163	0.37077282862167005
NEURONAL INTESTINAL DYSPLASIA, TYPE B	0.00408163	0.37077282862167005
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.00408163	0.37077282862167005
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.00408163	0.37077282862167005
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.00408163	0.37077282862167005
METAPHYSEAL CHONDRODYSPLASIA, PENA TYPE	0.00408163	0.37077282862167005
#261000 INTRINSIC FACTOR DEFICIENCY; IFD;;PERNICIOUS ANEMIA, CONGENITAL, DUE TO DEFECT OF INTRINSIC FACTOR	0.00408163	0.37077282862167005
PITUITARY DWARFISM IV	0.00408163	0.37077282862167005
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.00408163	0.37077282862167005
T-SUBSTANCE ANOMALY	0.00408163	0.37077282862167005
ADRENAL HYPOPLASIA, CONGENITAL, WITH ABSENT PITUITARY LUTEINIZINGHORMONE	0.00408163	0.37077282862167005
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.00408163	0.37077282862167005
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.00408163	0.37077282862167005
ANEMIA, AUTOIMMUNE HEMOLYTIC	0.00408163	0.37077282862167005
ICHTHYOSIS AND MALE HYPOGONADISM	0.00408163	0.37077282862167005
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00408163	0.37077282862167005
NEUTROPHIL ACTIN DYSFUNCTION	0.00408163	0.37077282862167005
ALKAPTONURIA	0.00408163	0.37077282862167005
CEREBELLOPARENCHYMAL DISORDER V	0.00408163	0.37077282862167005
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.00408163	0.37077282862167005
OVARIAN CANCER	0.00408163	0.37077282862167005
OCULORENOCEREBELLAR SYNDROME	0.00408163	0.37077282862167005
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.00408163	0.37077282862167005
MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT	0.00408163	0.37077282862167005
%270150 SJOGREN SYNDROME;;SICCA SYNDROME	0.00408163	0.37077282862167005
NORMOKALEMIC PERIODIC PARALYSIS	0.00408163	0.37077282862167005
SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION	0.00408163	0.37077282862167005
257960 OCULOTRICHODYSPLASIA; OTD	0.00408163	0.37077282862167005
DOPAMINE BETA-HYDROXYLASE, PLASMA, THERMOLABILITY OF	0.00408163	0.37077282862167005
#270960 SPERMATOGENIC FAILURE 4; SPGF4;;AZOOSPERMIA DUE TO PERTURBATIONS OF MEIOSIS;;AZOOSPERMIA WITH MATURATION ARREST;;SPERMATOGENESIS ARRESTPREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 4; RPRGL4	0.00408163	0.37077282862167005
VERTEBRAL FUSION, POSTERIOR LUMBOSACRAL, WITH BLEPHAROPTOSIS	0.00408163	0.37077282862167005
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.00408163	0.37077282862167005
BEETURIA	0.00408163	0.37077282862167005
WHITE SPONGE NEVUS OF CANNON	0.00408163	0.37077282862167005
SCHIZOPHRENIA 4	0.00408163	0.37077282862167005
ERYTHROCYTOSIS, FAMILIAL, 8; ECYT8	0.00408163	0.37077282862167005
DERMATITIS, ATOPIC	0.00408163	0.37077282862167005
GLOMUVENOUS MALFORMATIONS	0.00408163	0.37077282862167005
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.00408163	0.37077282862167005
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.00408163	0.37077282862167005
#256050 ATELOSTEOGENESIS, TYPE II; AOII;;AO2;;NEONATAL OSSEOUS DYSPLASIA IDE LA CHAPELLE DYSPLASIA, INCLUDED; DLCD, INCLUDED	0.00408163	0.37077282862167005
OSTEOGENESIS IMPERFECTA, TYPE V	0.00408163	0.37077282862167005
LARON SYNDROME	0.00408163	0.37077282862167005
#609152 HYPERTHYROIDISM, NONAUTOIMMUNE;;HYPERTHYROIDISM, CONGENITAL NONAUTOIMMUNE;;HYPERTHYROIDISM, NONAUTOIMMUNE, AUTOSOMAL DOMINANT;;TOXIC THYROID HYPERPLASIA, AUTOSOMAL DOMINANT	0.00408163	0.37077282862167005
TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS	0.00408163	0.37077282862167005
600459 ARTERIAL DISSECTION WITH LENTIGINOSIS	0.00408163	0.37077282862167005
HYPOGONADOTROPIC HYPOGONADISM 23 WITHOUT ANOSMIA; HH23	0.00408163	0.37077282862167005
CORONARY ARTERY DISSECTION, SPONTANEOUS	0.00408163	0.37077282862167005
ZINC, ELEVATED PLASMA	0.00408163	0.37077282862167005
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.00408163	0.37077282862167005
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.00408163	0.37077282862167005
%608572 BURN-MCKEOWN SYNDROME	0.00408163	0.37077282862167005
NEPHROSIALIDOSIS	0.00408163	0.37077282862167005
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.00408163	0.37077282862167005
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2	0.00408163	0.37077282862167005
PERRY SYNDROME	0.00408163	0.37077282862167005
URATE-BINDING GLOBULIN, DECREASE IN	0.00408163	0.37077282862167005
COUMARIN RESISTANCE	0.00408163	0.37077282862167005
FINGERPRINT BODY MYOPATHY	0.00408163	0.37077282862167005
SPERMATOGENIC FAILURE, X-LINKED, 2; SPGFX2	0.00408163	0.37077282862167005
LIPASE DEFICIENCY, COMBINED	0.00408163	0.37077282862167005
PELVIC LIPOMATOSIS WITH CROSSED RENAL ECTOPIA	0.00408163	0.37077282862167005
SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL	0.00408163	0.37077282862167005
XANTHINURIA, TYPE I	0.00408163	0.37077282862167005
THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	0.00408163	0.37077282862167005
MYOPATHY, GRANULOVACUOLAR LOBULAR, WITH ELECTRICAL MYOTONIA	0.00408163	0.37077282862167005
ACETYLATION, SLOW	0.00408163	0.37077282862167005
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.00408163	0.37077282862167005
KERATOSIS, FAMILIAL ACTINIC	0.00408163	0.37077282862167005
MYOTONIC MYOPATHY WITH CYLINDRICAL SPIRALS	0.00408163	0.37077282862167005
LYMPHOKINE DEFICIENCY	0.00408163	0.37077282862167005
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.00408163	0.37077282862167005
CARBOXYLESTERASE 1	0.00408163	0.37077282862167005
ONCOCYTOMA	0.00408163	0.37077282862167005
APOLIPOPROTEIN(A)	0.00408163	0.37077282862167005
256720 NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY	0.00408163	0.37077282862167005
#301200 AMELOGENESIS IMPERFECTA, TYPE IE; AI1E;;AMELOGENESIS IMPERFECTA, HYPOPLASTIC/HYPOMATURATION, X-LINKED 1;;AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, WITH SNOW-CAPPED TEETH;;AMELOGENESIS IMPERFECTA, X-LINKED 1; AIH1;;ENAMEL HYPOPLASIA, X-LINKED	0.00408163	0.37077282862167005
MACROCYTOSIS, FAMILIAL	0.00408163	0.37077282862167005
CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION	0.00408163	0.37077282862167005
ETHANOLAMINOSIS	0.00408163	0.37077282862167005
HYPOASCORBEMIA	0.00408163	0.37077282862167005
XM SYSTEM	0.00408163	0.37077282862167005
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00408163	0.37077282862167005
CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	0.00408163	0.37077282862167005
LISSENCEPHALY TYPE III AND BONE DYSPLASIA	0.00408163	0.37077282862167005
GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUETO	0.00408163	0.37077282862167005
PARAOXONASE 1	0.00408163	0.37077282862167005
SPERMATOGENIC FAILURE 1; SPGF1	0.00408163	0.37077282862167005
#217095 CONOTRUNCAL HEART MALFORMATIONS; CTHMTRUNCUS ARTERIOSUS COMMUNIS, INCLUDED;;CONOTRUNCAL ANOMALY FACE SYNDROME, INCLUDED; CAFS, INCLUDED;;DOUBLE-OUTLET RIGHT VENTRICLE, INCLUDED; DORV, INCLUDED;;PERSISTENT TRUNCUS ARTERIOSUS, INCLUDED; PTA, INCLUDED;;INTERRUPTED AORTIC ARCH, INCLUDED	0.00408163	0.37077282862167005
%253240 MUCUS INSPISSATION OF RESPIRATORY TRACT	0.00408163	0.37077282862167005
ASPLENIA, ISOLATED CONGENITAL; ICAS	0.00408163	0.37077282862167005
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00408163	0.37077282862167005
238800 HYPERMETABOLISM DUE TO DEFECT IN MITOCHONDRIA	0.00408163	0.37077282862167005
THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	0.00408163	0.37077282862167005
CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 2	0.00408163	0.37077282862167005
#235700 HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO HEXOKINASE DEFICIENCY	0.00408163	0.37077282862167005
#203655 ALOPECIA UNIVERSALIS CONGENITA; ALUNC;;ATRICHIA, GENERALIZED	0.00408163	0.37077282862167005
HYPOGONADOTROPIC HYPOGONADISM 24 WITHOUT ANOSMIA; HH24	0.00408163	0.37077282862167005
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.00408163	0.37077282862167005
601195 IRON OVERLOAD IN AFRICA;;AFRICAN IRON OVERLOAD;;BANTU SIDEROSIS	0.00408163	0.37077282862167005
FLOOD FACTOR DEFICIENCY	0.00408163	0.37077282862167005
ALAND ISLAND EYE DISEASE	0.00408163	0.37077282862167005
LYMPHOBLASTIC TRANSFORMATION, INHIBITION OF	0.00408163	0.37077282862167005
AMOBARBITAL, DEFICIENT N-HYDROXYLATION OF	0.00408163	0.37077282862167005
HYPERPROGLUCAGONEMIA	0.00408163	0.37077282862167005
HOOFT DISEASE	0.00408163	0.37077282862167005
METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA; METAG	0.00408163	0.37077282862167005
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00408163	0.37077282862167005
DELETED IN AZOOSPERMIA	0.00408163	0.37077282862167005
17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	0.00408163	0.37077282862167005
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.00408163	0.37077282862167005
EPOXIDE HYDROLASE 1, MICROSOMAL	0.00408163	0.37077282862167005
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.00408163	0.37077282862167005
#192600 CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1; CMH1;;CMH;;VENTRICULAR HYPERTROPHY, HEREDITARY;;ASYMMETRIC SEPTAL HYPERTROPHY; ASH;;HYPERTROPHIC SUBAORTIC STENOSIS, IDIOPATHIC	0.00408163	0.37077282862167005
DRUG METABOLISM, POOR, CYP2D6-RELATEDDRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED	0.00408163	0.37077282862167005
HYPERLEUCINE-ISOLEUCINEMIA	0.00408163	0.37077282862167005
ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	0.00408163	0.37077282862167005
PROGESTERONE RESISTANCE	0.00408163	0.37077282862167005
PYGMY	0.00408163	0.37077282862167005
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1; AHMIO1	0.00408163	0.37077282862167005
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS, X-LINKED	0.00408163	0.37077282862167005
#212840 CEREBELLAR ATAXIA AND HYPOGONADOTROPIC HYPOGONADISM; CAHH;;GORDON HOLMES SYNDROME;;LUTEINIZING HORMONE-RELEASING HORMONE, DEFICIENCY OF, WITH ATAXIA;;LHRH DEFICIENCY AND ATAXIA	0.00408163	0.37077282862167005
SPINAL ARACHNOIDITIS	0.00408163	0.37077282862167005
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00408163	0.37077282862167005
#143860 HYPERCHLORHIDROSIS, ISOLATED	0.00408163	0.37077282862167005
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.00408163	0.37077282862167005
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.00408163	0.37077282862167005
CHOROIDAL OSTEOMA, BILATERAL	0.00408163	0.37077282862167005
GLUTATHIONURIA	0.00408163	0.37077282862167005
PROPERDIN DEFICIENCY, X-LINKED	0.00408163	0.37077282862167005
NEURAL TUBE DEFECTS, FOLATE-SENSITIVE	0.00408163	0.37077282862167005
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.00408163	0.37077282862167005
GLUTATHIONE REDUCTASE	0.00408163	0.37077282862167005
TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN	0.00408163	0.37077282862167005
CEPHALIN LIPIDOSIS	0.00408163	0.37077282862167005
LUTHERAN SUPPRESSOR, X-LINKED	0.00408163	0.37077282862167005
ICHTHYOSIS, X-LINKED	0.00408163	0.37077282862167005
INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP	0.00408163	0.37077282862167005
HEINZ BODY ANEMIAS	0.00408163	0.37077282862167005
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1; EV1	0.00408163	0.37077282862167005
HYPERTELORISM AND TETRALOGY OF FALLOT	0.00325733	0.2958939095053262
#163950 NOONAN SYNDROME 1; NS1;;NOONAN SYNDROME;;MALE TURNER SYNDROME;;FEMALE PSEUDO-TURNER SYNDROME;;TURNER PHENOTYPE WITH NORMAL KARYOTYPEPTERYGIUM COLLI SYNDROME, INCLUDED	0.00325733	0.2958939095053262
PALLISTER-KILLIAN SYNDROME	0.00325733	0.2958939095053262
DUANE-RADIAL RAY SYNDROME; DRRS	0.00325733	0.2958939095053262
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.00325733	0.2958939095053262
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.00325733	0.2958939095053262
SCALP-EAR-NIPPLE SYNDROME; SENS	0.00325733	0.2958939095053262
EHLERS-DANLOS SYNDROME, TYPE I	0.00325733	0.2958939095053262
#151100 LEOPARD SYNDROME 1;;LENTIGINOSIS, CARDIOMYOPATHIC;;MULTIPLE LENTIGINES SYNDROME	0.00325733	0.2958939095053262
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.00325733	0.2958939095053262
#265000 MULTIPLE PTERYGIUM SYNDROME, ESCOBAR VARIANT; EVMPS;;ESCOBAR SYNDROME;;MULTIPLE PTERYGIUM SYNDROME, NONLETHAL TYPE;;PTERYGIUM SYNDROME;;MULTIPLE PTERYGIUM SYNDROME;;PTERYGIUM COLLI SYNDROME;;PTERYGIUM UNIVERSALE	0.00325733	0.2958939095053262
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.00325733	0.2958939095053262
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.00325733	0.2958939095053262
600736 VELOFACIOSKELETAL SYNDROME	0.00325733	0.2958939095053262
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.00325733	0.2958939095053262
CHROMOSOME 17q12 DELETION SYNDROME	0.00325733	0.2958939095053262
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00325733	0.2958939095053262
CHROMOSOME 13q14 DELETION SYNDROME	0.00325733	0.2958939095053262
LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA	0.00325733	0.2958939095053262
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.00325733	0.2958939095053262
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.00325733	0.2958939095053262
#177980 PTERYGIA, MENTAL RETARDATION, AND DISTINCTIVE CRANIOFACIAL FEATURES;;HASPESLAGH SYNDROME	0.00325733	0.2958939095053262
PTERYGIUM COLLI, ISOLATED	0.00325733	0.2958939095053262
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.00325733	0.2958939095053262
SCHOLTE SYNDROME; SHLTS	0.00325733	0.2958939095053262
SHPRINTZEN OMPHALOCELE SYNDROME	0.00325733	0.2958939095053262
SIFRIM-HITZ-WEISS SYNDROME	0.00325733	0.2958939095053262
ZUNICH NEUROECTODERMAL SYNDROME	0.00325733	0.2958939095053262
NOONAN SYNDROME 8; NS8	0.00325733	0.2958939095053262
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.00325733	0.2958939095053262
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00325733	0.2958939095053262
CHROMOSOME 3q13.31 DELETION SYNDROME	0.00325733	0.2958939095053262
JOUBERT SYNDROME 3; JBTS3	0.00325733	0.2958939095053262
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.00325733	0.2958939095053262
#616006 HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 2; HKLLS2	0.00325733	0.2958939095053262
133705 EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICALTALUS;;RASMUSSEN SYNDROME	0.00325733	0.2958939095053262
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.00325733	0.2958939095053262
#611554 LEOPARD SYNDROME 2	0.00325733	0.2958939095053262
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.00325733	0.2958939095053262
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.00325733	0.2958939095053262
MECKEL SYNDROME, TYPE 10; MKS10	0.00325733	0.2958939095053262
TERMINAL OSSEOUS DYSPLASIA; TOD	0.00325733	0.2958939095053262
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.00325733	0.2958939095053262
EPICANTHUS	0.00325733	0.2958939095053262
OROFACIODIGITAL SYNDROME IV; OFD4	0.00325733	0.2958939095053262
#154780 MARSHALL SYNDROME; MRSHS	0.00325733	0.2958939095053262
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.00325733	0.2958939095053262
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.00325733	0.2958939095053262
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.00325733	0.2958939095053262
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.00325733	0.2958939095053262
#108145 ARTHROGRYPOSIS, DISTAL, TYPE 5; DA5;;ARTHROGRYPOSIS WITH OCULOMOTOR LIMITATION AND ELECTRORETINAL ABNORMALITIES;;OCULOMELIC AMYOPLASIA;;ARTHROGRYPOSIS, DISTAL, TYPE IIB; DAIIB	0.00325733	0.2958939095053262
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.00325733	0.2958939095053262
#101800 ACRODYSOSTOSIS 1, WITH OR WITHOUT HORMONE RESISTANCE; ACRDYS1;;ADOHR	0.00325733	0.2958939095053262
ACROCALLOSAL SYNDROME; ACLS	0.00325733	0.2958939095053262
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.00325733	0.2958939095053262
OMODYSPLASIA 1; OMOD1	0.00325733	0.2958939095053262
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.00325733	0.2958939095053262
#225410 EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL RECESSIVE;;EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE;;DERMATOSPARAXIS;;EDS VIIC;;EDS7C	0.00325733	0.2958939095053262
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.00325733	0.2958939095053262
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.00325733	0.2958939095053262
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.00325733	0.2958939095053262
VAN MALDERGEM SYNDROME 2; VMLDS2	0.00325733	0.2958939095053262
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.00325733	0.2958939095053262
VAN MALDERGEM SYNDROME 1; VMLDS1	0.00325733	0.2958939095053262
NOONAN SYNDROME 4; NS4	0.00325733	0.2958939095053262
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.00325733	0.2958939095053262
PFEIFFER-PALM-TELLER SYNDROME	0.00325733	0.2958939095053262
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.00325733	0.2958939095053262
#201000 CARPENTER SYNDROME 1; CRPT1;;CARPENTER SYNDROME;;ACROCEPHALOPOLYSYNDACTYLY TYPE II;;ACPS II	0.00325733	0.2958939095053262
Mulchandani-Bhoj-Conlin syndrome	0.00325733	0.2958939095053262
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.00325733	0.2958939095053262
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.00325733	0.2958939095053262
LEGIUS SYNDROME	0.00325733	0.2958939095053262
OHDO SYNDROME	0.00325733	0.2958939095053262
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00325733	0.2958939095053262
#190685 DOWN SYNDROMETRISOMY 21, INCLUDED;;DOWN SYNDROME CHROMOSOME REGION, INCLUDED; DCR, INCLUDED;;DOWN SYNDROME CRITICAL REGION, INCLUDED; DSCR, INCLUDED;;TRANSIENT MYELOPROLIFERATIVE DISORDER OF DOWN SYNDROME, INCLUDED;;LEUKEMIA, MEGAKARYOBLASTIC, OF DOWN SYNDROME, INCLUDED	0.00325733	0.2958939095053262
EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2; EDSCL2	0.00325733	0.2958939095053262
OROFACIAL CLEFT 15	0.00325733	0.2958939095053262
POTOCKI-SHAFFER SYNDROME	0.00325733	0.2958939095053262
#253290 MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE; LMPS;;PTERYGIUM SYNDROME, MULTIPLE, LETHAL TYPE	0.00325733	0.2958939095053262
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.00325733	0.2958939095053262
#218600 BALLER-GEROLD SYNDROME; BGS;;CRANIOSYNOSTOSIS WITH RADIAL DEFECTS;;CRANIOSYNOSTOSIS-RADIAL APLASIA SYNDROME	0.00325733	0.2958939095053262
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.00325733	0.2958939095053262
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.00325733	0.2958939095053262
MEGAEPIPHYSEAL DWARFISM	0.00325733	0.2958939095053262
HYPOGLOSSIA-HYPODACTYLIA	0.00325733	0.2958939095053262
FRONTONASAL DYSPLASIA 1; FND1	0.00325733	0.2958939095053262
115645 CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION	0.00325733	0.2958939095053262
CRANIOECTODERMAL DYSPLASIA 1	0.00325733	0.2958939095053262
#613506 AGAMMAGLOBULINEMIA 5, AUTOSOMAL DOMINANT; AGM5;;AGAMMAGLOBULINEMIA, AUTOSOMAL DOMINANT, DUE TO LRRC8A DEFECT	0.00325733	0.2958939095053262
BRITTLE CORNEA SYNDROME	0.00325733	0.2958939095053262
#611881 GLYCOGEN STORAGE DISEASE XII; GSD12;;GSD XII;;ALDOLASE A DEFICIENCY;;ALDOA DEFICIENCY;;ALDOLASE DEFICIENCY, RED CELL;;RED CELL ALDOLASE DEFICIENCY	0.00325733	0.2958939095053262
#162100 AMYOTROPHY, HEREDITARY NEURALGIC; HNA;;NEURITIS WITH BRACHIAL PREDILECTION; NAPB;;BRACHIAL PLEXUS NEUROPATHY, HEREDITARY;;AMYOTROPHY, HEREDITARY NEURALGIC, WITH PREDILECTION FOR BRACHIAL PLEXUS	0.00325733	0.2958939095053262
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.0021193920000000003	0.19252430200634027
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.0021193920000000003	0.19252430200634027
#610758 CEREBROOCULOFACIOSKELETAL SYNDROME 4; COFS4	0.0021193920000000003	0.19252430200634027
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.0021193920000000003	0.19252430200634027
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.0021193920000000003	0.19252430200634027
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.0021193920000000003	0.19252430200634027
SECKEL SYNDROME 8; SCKL8	0.0021193920000000003	0.19252430200634027
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.0021193920000000003	0.19252430200634027
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.0021193920000000003	0.19252430200634027
BETA-UREIDOPROPIONASE DEFICIENCY	0.0021193920000000003	0.19252430200634027
#251290 BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA;BLCPMG;;PSEUDO-TORCH SYNDROME	0.0021193920000000003	0.19252430200634027
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.0021193920000000003	0.19252430200634027
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.0021193920000000003	0.19252430200634027
HOLOPROSENCEPHALY 2; HPE2	0.0021193920000000003	0.19252430200634027
WHITE-SUTTON SYNDROME; WHSUS	0.0021193920000000003	0.19252430200634027
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.0021193920000000003	0.19252430200634027
#611936 CHROMOSOME 3q29 DUPLICATION SYNDROME;;MICRODUPLICATION 3q29 SYNDROME	0.0021193920000000003	0.19252430200634027
Leukotriene C4 synthase deficiency	0.0021193920000000003	0.19252430200634027
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.0021193920000000003	0.19252430200634027
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.0021193920000000003	0.19252430200634027
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.0021193920000000003	0.19252430200634027
HOLOPROSENCEPHALY 3; HPE3	0.0021193920000000003	0.19252430200634027
MARINESCO-SJOGREN SYNDROME; MSS	0.0021193920000000003	0.19252430200634027
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.0021193920000000003	0.19252430200634027
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.0021193920000000003	0.19252430200634027
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip; CDG1P	0.0021193920000000003	0.19252430200634027
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.0021193920000000003	0.19252430200634027
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.0021193920000000003	0.19252430200634027
MEHMO SYNDROME; MEHMO	0.0021193920000000003	0.19252430200634027
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.0021193920000000003	0.19252430200634027
Xq28 (MECP2) duplication	0.0021193920000000003	0.19252430200634027
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.0021193920000000003	0.19252430200634027
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.0021193920000000003	0.19252430200634027
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.0021193920000000003	0.19252430200634027
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.0021193920000000003	0.19252430200634027
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.0021193920000000003	0.19252430200634027
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.0021193920000000003	0.19252430200634027
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.0021193920000000003	0.19252430200634027
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.0021193920000000003	0.19252430200634027
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.0021193920000000003	0.19252430200634027
#610829 HOLOPROSENCEPHALY 9; HPE9;;PITUITARY ANOMALIES WITH HOLOPROSENCEPHALY-LIKE FEATURES;;HOLOPROSENCEPHALY WITH MICROPHTHALMIA AND FIRST BRANCHIAL ARCH ANOMALIES	0.0021193920000000003	0.19252430200634027
ADAMS-OLIVER SYNDROME 3; AOS3	0.0021193920000000003	0.19252430200634027
TONNE-KALSCHEUER SYNDROME; TOKAS	0.0021193920000000003	0.19252430200634027
2,4-DIENOYL-CoA REDUCTASE DEFICIENCY; DECRD	0.0021193920000000003	0.19252430200634027
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.0021193920000000003	0.19252430200634027
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il; CDG1L	0.0021193920000000003	0.19252430200634027
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.0021193920000000003	0.19252430200634027
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.0021193920000000003	0.19252430200634027
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.0021193920000000003	0.19252430200634027
#614728 SECKEL SYNDROME 6; SCKL6	0.0021193920000000003	0.19252430200634027
AL-RAQAD SYNDROME; ARS	0.0021193920000000003	0.19252430200634027
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.0021193920000000003	0.19252430200634027
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.0021193920000000003	0.19252430200634027
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.0021193920000000003	0.19252430200634027
#612938 GROWTH RETARDATION, DEVELOPMENTAL DELAY, COARSE FACIES, AND EARLYDEATH; GDFD	0.0021193920000000003	0.19252430200634027
JABERI-ELAHI SYNDROME; JABELS	0.0021193920000000003	0.19252430200634027
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.0021193920000000003	0.19252430200634027
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.0021193920000000003	0.19252430200634027
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.0021193920000000003	0.19252430200634027
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix; CDG1X	0.0021193920000000003	0.19252430200634027
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.0021193920000000003	0.19252430200634027
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iy; CDG1Y	0.0021193920000000003	0.19252430200634027
MACDERMOT-WINTER SYNDROME	0.0021193920000000003	0.19252430200634027
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.0021193920000000003	0.19252430200634027
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.0021193920000000003	0.19252430200634027
CHROMOSOME 17q23.1-q23.2 DELETION SYNDROME	0.0021193920000000003	0.19252430200634027
KLEEFSTRA SYNDROME 2; KLEFS2	0.0021193920000000003	0.19252430200634027
CHROMOSOME 16p13.3 DELETION SYNDROME	0.0021193920000000003	0.19252430200634027
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.0021193920000000003	0.19252430200634027
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.0021193920000000003	0.19252430200634027
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.0021193920000000003	0.19252430200634027
CRANIOSYNOSTOSIS 6; CRS6	0.0021193920000000003	0.19252430200634027
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.0021193920000000003	0.19252430200634027
COFFIN-SIRIS SYNDROME 5	0.0021193920000000003	0.19252430200634027
KBG SYNDROME	0.0021193920000000003	0.19252430200634027
FORSYTHE-WAKELING SYNDROME; FWS	0.0021193920000000003	0.19252430200634027
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.0021193920000000003	0.19252430200634027
PELIZAEUS-MERZBACHER DISEASE	0.0021193920000000003	0.19252430200634027
#615583 VERHEIJ SYNDROME; VRJS;;CHROMOSOME 8q24.3 DELETION SYNDROME	0.0021193920000000003	0.19252430200634027
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.0021193920000000003	0.19252430200634027
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.0021193920000000003	0.19252430200634027
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.0021193920000000003	0.19252430200634027
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.0021193920000000003	0.19252430200634027
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.0021193920000000003	0.19252430200634027
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.0021193920000000003	0.19252430200634027
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.0021193920000000003	0.19252430200634027
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.0021193920000000003	0.19252430200634027
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.0021193920000000003	0.19252430200634027
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.0021193920000000003	0.19252430200634027
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.0021193920000000003	0.19252430200634027
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik; CDG1K	0.0021193920000000003	0.19252430200634027
LISSENCEPHALY 2; LIS2	0.0021193920000000003	0.19252430200634027
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.0021193920000000003	0.19252430200634027
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.0021193920000000003	0.19252430200634027
#615182 COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA; D2L2AD	0.0021193920000000003	0.19252430200634027
#609425 CHROMOSOME 3q29 DELETION SYNDROME;;MICRODELETION 3q29 SYNDROME	0.0021193920000000003	0.19252430200634027
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.0021193920000000003	0.19252430200634027
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.0021193920000000003	0.19252430200634027
KABUKI SYNDROME 1	0.0021193920000000003	0.19252430200634027
#604804 MICROCEPHALY 3, PRIMARY, AUTOSOMAL RECESSIVE; MCPH3	0.0021193920000000003	0.19252430200634027
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.0021193920000000003	0.19252430200634027
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.0021193920000000003	0.19252430200634027
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.0021193920000000003	0.19252430200634027
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.0021193920000000003	0.19252430200634027
N-ACETYLASPARTATE DEFICIENCY; NACED	0.0021193920000000003	0.19252430200634027
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.0021193920000000003	0.19252430200634027
AICARDI-GOUTIERES SYNDROME 5	0.0021193920000000003	0.19252430200634027
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.0021193920000000003	0.19252430200634027
DYSTONIA 28, CHILDHOOD-ONSET	0.0021193920000000003	0.19252430200634027
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.0021193920000000003	0.19252430200634027
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.0021193920000000003	0.19252430200634027
ADAMS-OLIVER SYNDROME 1; AOS1	0.0021193920000000003	0.19252430200634027
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.0021193920000000003	0.19252430200634027
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.0021193920000000003	0.19252430200634027
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.0021193920000000003	0.19252430200634027
GLASS SYNDROME	0.0021193920000000003	0.19252430200634027
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.0021193920000000003	0.19252430200634027
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.0021193920000000003	0.19252430200634027
MENTAL RETARDATION, X-LINKED 106; MRX106	0.0021193920000000003	0.19252430200634027
ADAMS-OLIVER SYNDROME 2; AOS2	0.0021193920000000003	0.19252430200634027
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.0021193920000000003	0.19252430200634027
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.0021193920000000003	0.19252430200634027
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.0021193920000000003	0.19252430200634027
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.0021193920000000003	0.19252430200634027
LISSENCEPHALY 8; LIS8	0.0021193920000000003	0.19252430200634027
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.0021193920000000003	0.19252430200634027
CHROMOSOME 19p13.13 DELETION SYNDROME	0.0021193920000000003	0.19252430200634027
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.0021193920000000003	0.19252430200634027
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.0021193920000000003	0.19252430200634027
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.0021193920000000003	0.19252430200634027
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.0021193920000000003	0.19252430200634027
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.0021193920000000003	0.19252430200634027
OROFACIODIGITAL SYNDROME IX; OFD9	0.0021193920000000003	0.19252430200634027
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.0021193920000000003	0.19252430200634027
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.0021193920000000003	0.19252430200634027
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.0021193920000000003	0.19252430200634027
Pierpont syndrome	0.0021193920000000003	0.19252430200634027
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.0021193920000000003	0.19252430200634027
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.0021193920000000003	0.19252430200634027
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.0021193920000000003	0.19252430200634027
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.0021193920000000003	0.19252430200634027
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.0021193920000000003	0.19252430200634027
ROIFMAN SYNDROME; RFMN	0.0021193920000000003	0.19252430200634027
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.0021193920000000003	0.19252430200634027
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.0021193920000000003	0.19252430200634027
#604317 MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CORTICALMALFORMATIONS; MCPH2	0.0021193920000000003	0.19252430200634027
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.0021193920000000003	0.19252430200634027
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.0021193920000000003	0.19252430200634027
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.0021193920000000003	0.19252430200634027
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.0021193920000000003	0.19252430200634027
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.0021193920000000003	0.19252430200634027
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.0021193920000000003	0.19252430200634027
MUCOLIPIDOSIS IV; ML4	0.0021193920000000003	0.19252430200634027
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.0021193920000000003	0.19252430200634027
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.0021193920000000003	0.19252430200634027
GENITOPATELLAR SYNDROME; GTPTS	0.0021193920000000003	0.19252430200634027
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.0021193920000000003	0.19252430200634027
HEART AND BRAIN MALFORMATION SYNDROME	0.0021193920000000003	0.19252430200634027
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.0021193920000000003	0.19252430200634027
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.0021193920000000003	0.19252430200634027
WIEACKER-WOLFF SYNDROME	0.0021193920000000003	0.19252430200634027
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.0021193920000000003	0.19252430200634027
LIG4 SYNDROME	0.0021193920000000003	0.19252430200634027
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.0021193920000000003	0.19252430200634027
MICROPHTHALMIA, SYNDROMIC 3	0.0021193920000000003	0.19252430200634027
PETERS-PLUS SYNDROME; PTRPLS	0.0021193920000000003	0.19252430200634027
RAINE SYNDROME	0.0021193920000000003	0.19252430200634027
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.0021193920000000003	0.19252430200634027
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.0021193920000000003	0.19252430200634027
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.0021193920000000003	0.19252430200634027
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.0021193920000000003	0.19252430200634027
%300712 CRANIOFACIOSKELETAL SYNDROME	0.0021193920000000003	0.19252430200634027
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.0021193920000000003	0.19252430200634027
ADENYLOSUCCINASE DEFICIENCY	0.0021193920000000003	0.19252430200634027
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.0021193920000000003	0.19252430200634027
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.0021193920000000003	0.19252430200634027
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.0021193920000000003	0.19252430200634027
COFFIN-SIRIS SYNDROME 3; CSS3	0.0021193920000000003	0.19252430200634027
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.0021193920000000003	0.19252430200634027
MEVALONIC ACIDURIA; MEVA	0.0021193920000000003	0.19252430200634027
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.0021193920000000003	0.19252430200634027
CHROMOSOME 1p35 DELETION SYNDROME	0.0021193920000000003	0.19252430200634027
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.0021193920000000003	0.19252430200634027
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.0021193920000000003	0.19252430200634027
#612626 CHROMOSOME 15q26-qter DELETION SYNDROME;;DRAYER SYNDROME	0.0021193920000000003	0.19252430200634027
#231550 ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME; AAAS;;TRIPLE-A SYNDROME;;ALACRIMA-ACHALASIA-ADRENAL INSUFFICIENCY NEUROLOGIC DISORDER;;GLUCOCORTICOID DEFICIENCY AND ACHALASIA;;ALLGROVE SYNDROME;;ADDISONIAN-ACHALASIA SYNDROME;;HYPOADRENALISM WITH ACHALASIA;;ALACRIMA-ACHALASIA-ADDISONIANISM;;ACTH-RESISTANT ADRENAL INSUFFICIENCY, ACHALASIA AND ALACRIMAACHALASIA-ALACRIMA SYNDROME, INCLUDED	0.0021193920000000003	0.19252430200634027
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.0021193920000000003	0.19252430200634027
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.0021193920000000003	0.19252430200634027
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.0021193920000000003	0.19252430200634027
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.0021193920000000003	0.19252430200634027
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.0021193920000000003	0.19252430200634027
LISSENCEPHALY 4	0.0021193920000000003	0.19252430200634027
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.0021193920000000003	0.19252430200634027
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.0021193920000000003	0.19252430200634027
HOLOPROSENCEPHALY 1; HPE1	0.0021193920000000003	0.19252430200634027
ALAZAMI SYNDROME; ALAZS	0.0021193920000000003	0.19252430200634027
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.0021193920000000003	0.19252430200634027
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.0021193920000000003	0.19252430200634027
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.0021193920000000003	0.19252430200634027
CHROMOSOME 1q41-q42 DELETION SYNDROME	0.0021193920000000003	0.19252430200634027
#269000 SC PHOCOMELIA SYNDROME;;SC PSEUDOTHALIDOMIDE SYNDROME	0.0021193920000000003	0.19252430200634027
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.0021193920000000003	0.19252430200634027
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw; CDG1W	0.0021193920000000003	0.19252430200634027
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.0021193920000000003	0.19252430200634027
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.0021193920000000003	0.19252430200634027
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.0021193920000000003	0.19252430200634027
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.0021193920000000003	0.19252430200634027
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.0021193920000000003	0.19252430200634027
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.0021193920000000003	0.19252430200634027
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.0021193920000000003	0.19252430200634027
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.0021193920000000003	0.19252430200634027
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.0021193920000000003	0.19252430200634027
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.0021193920000000003	0.19252430200634027
OPTIC ATROPHY 11; OPA11	0.0021193920000000003	0.19252430200634027
#612716 DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY;;SEPIAPTERIN REDUCTASE DEFICIENCY;;SPR DEFICIENCY	0.0021193920000000003	0.19252430200634027
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.0021193920000000003	0.19252430200634027
#614457 ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR	0.0021193920000000003	0.19252430200634027
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.0021193920000000003	0.19252430200634027
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.0021193920000000003	0.19252430200634027
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij; CDG1J	0.0021193920000000003	0.19252430200634027
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.0021193920000000003	0.19252430200634027
COFFIN-SIRIS SYNDROME 4; CSS4	0.0021193920000000003	0.19252430200634027
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.0021193920000000003	0.19252430200634027
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.0021193920000000003	0.19252430200634027
CEREBELLOFACIODENTAL SYNDROME	0.0021193920000000003	0.19252430200634027
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf; CDG2F	0.0021193920000000003	0.19252430200634027
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.0021193920000000003	0.19252430200634027
#613180 POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.0021193920000000003	0.19252430200634027
TOWNES-BROCKS SYNDROME 1; TBS1	0.0021193920000000003	0.19252430200634027
#612936 SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE; SPG50;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3, FORMERLY; CPSQ3, FORMERLY	0.0021193920000000003	0.19252430200634027
OROFACIODIGITAL SYNDROME XIV; OFD14	0.0021193920000000003	0.19252430200634027
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.0021193920000000003	0.19252430200634027
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.0021193920000000003	0.19252430200634027
LOWRY-MACLEAN SYNDROME	0.0021193920000000003	0.19252430200634027
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.0021193920000000003	0.19252430200634027
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.0021193920000000003	0.19252430200634027
#613744 SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE; SPG51;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 4, FORMERLY; CPSQ4, FORMERLY	0.0021193920000000003	0.19252430200634027
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.0021193920000000003	0.19252430200634027
#614322 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12; SCAR12;;SPINOCEREBELLAR ATAXIA WITH MENTAL RETARDATION AND EPILEPSY	0.0021193920000000003	0.19252430200634027
TURNPENNY-FRY SYNDROME; TPFS	0.0021193920000000003	0.19252430200634027
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.0021193920000000003	0.19252430200634027
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.0021193920000000003	0.19252430200634027
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.0021193920000000003	0.19252430200634027
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.0021193920000000003	0.19252430200634027
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.0021193920000000003	0.19252430200634027
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.0021193920000000003	0.19252430200634027
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.0021193920000000003	0.19252430200634027
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.0021193920000000003	0.19252430200634027
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.0021193920000000003	0.19252430200634027
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.0021193920000000003	0.19252430200634027
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm; CDG2M	0.0021193920000000003	0.19252430200634027
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.0021193920000000003	0.19252430200634027
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.0021193920000000003	0.19252430200634027
SECKEL SYNDROME 9; SCKL9	0.0021193920000000003	0.19252430200634027
Wolf-Hirschhorn Syndrome	0.00127551	0.11586656571889817
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00127551	0.11586656571889817
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00127551	0.11586656571889817
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.00127551	0.11586656571889817
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.00127551	0.11586656571889817
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.00127551	0.11586656571889817
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.00127551	0.11586656571889817
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.00127551	0.11586656571889817
#615414 MICROCEPHALY 11, PRIMARY, AUTOSOMAL RECESSIVE; MCPH11	0.00127551	0.11586656571889817
LISSENCEPHALY 3; LIS3	0.00127551	0.11586656571889817
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.00127551	0.11586656571889817
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.00127551	0.11586656571889817
MECKEL SYNDROME, TYPE 1; MKS1	0.00127551	0.11586656571889817
#300558 MENTAL RETARDATION, X-LINKED 30; MRX30;;MENTAL RETARDATION, X-LINKED 47; MRX47	0.00127551	0.11586656571889817
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj; CDG2J	0.00127551	0.11586656571889817
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.00127551	0.11586656571889817
FRONTONASAL DYSPLASIA 2; FND2	0.00127551	0.11586656571889817
AORTIC ARCH ANOMALY WITH PECULIAR FACIES AND MENTAL RETARDATION	0.00127551	0.11586656571889817
ADDUCTED THUMBS SYNDROME	0.00127551	0.11586656571889817
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.00127551	0.11586656571889817
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00127551	0.11586656571889817
MICROCEPHALY 7, PRIMARY, AUTOSOMAL RECESSIVE	0.00127551	0.11586656571889817
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.00127551	0.11586656571889817
ISOLATED GROWTH HORMONE DEFICIENCY, TYPE V; IGHD5	0.00127551	0.11586656571889817
OCULOPALATOCEREBRAL SYNDROME	0.00127551	0.11586656571889817
JOHANSON-BLIZZARD SYNDROME; JBS	0.00127551	0.11586656571889817
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.00127551	0.11586656571889817
BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE	0.00127551	0.11586656571889817
FANCONI ANEMIA, COMPLEMENTATION GROUP D1	0.00127551	0.11586656571889817
#613078 NIJMEGEN BREAKAGE SYNDROME-LIKE DISORDER; NBSLD;;NBS-LIKE DISORDER;;RAD50 DEFICIENCY;;MICROCEPHALY AND SPONTANEOUS CHROMOSOME INSTABILITY WITHOUT IMMUNODEFICIENCY	0.00127551	0.11586656571889817
#219000 FRASER SYNDROME;;CRYPTOPHTHALMOS WITH OTHER MALFORMATIONSCRYPTOPHTHALMOS-SYNDACTYLY SYNDROME, INCLUDED	0.00127551	0.11586656571889817
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00127551	0.11586656571889817
#607326 SMITH-MCCORT DYSPLASIA 1; SMC1;;SMC	0.00127551	0.11586656571889817
SECKEL SYNDROME 5; SCKL5	0.00127551	0.11586656571889817
#612951 LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY	0.00127551	0.11586656571889817
#614082 FANCONI ANEMIA, COMPLEMENTATION GROUP G; FANCG	0.00127551	0.11586656571889817
#133540 COCKAYNE SYNDROME, TYPE B; CSB;;CKN2	0.00127551	0.11586656571889817
2p15-16.1 microdeletion syndrome	0.00127551	0.11586656571889817
MEIER-GORLIN SYNDROME 1; MGORS1	0.00127551	0.11586656571889817
#614852 MICROCEPHALY 9, PRIMARY, AUTOSOMAL RECESSIVE; MCPH9	0.00127551	0.11586656571889817
SUPRABULBAR PARESIS, CONGENITAL	0.00127551	0.11586656571889817
ROBERTS SYNDROME; RBS	0.00127551	0.11586656571889817
OSTEOGENESIS IMPERFECTA CONGENITA, MICROCEPHALY, AND CATARACTS	0.00127551	0.11586656571889817
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.00127551	0.11586656571889817
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.00127551	0.11586656571889817
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.00127551	0.11586656571889817
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.00127551	0.11586656571889817
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.00127551	0.11586656571889817
HYPOGONADISM WITH LOW-GRADE MENTAL DEFICIENCY AND MICROCEPHALY	0.00127551	0.11586656571889817
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.00127551	0.11586656571889817
AICARDI-GOUTIERES SYNDROME 2; AGS2	0.00127551	0.11586656571889817
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.00127551	0.11586656571889817
FANCONI ANEMIA, COMPLEMENTATION GROUP R	0.00127551	0.11586656571889817
MECKEL SYNDROME, TYPE 4; MKS4	0.00127551	0.11586656571889817
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.00127551	0.11586656571889817
MEIER-GORLIN SYNDROME 8; MGORS8	0.00127551	0.11586656571889817
#614485 TRIGONOCEPHALY 2; TRIGNO2;;CRANIOSYNOSTOSIS, METOPIC	0.00127551	0.11586656571889817
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.00127551	0.11586656571889817
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.00127551	0.11586656571889817
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.00127551	0.11586656571889817
NEU-LAXOVA SYNDROME 2; NLS2	0.00127551	0.11586656571889817
Angelman syndrome (Type 2)	0.00127551	0.11586656571889817
MASA SYNDROME	0.00127551	0.11586656571889817
COHEN SYNDROME	0.00127551	0.11586656571889817
MICROCEPHALY 18, PRIMARY, AUTOSOMAL DOMINANT; MCPH18	0.00127551	0.11586656571889817
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.00127551	0.11586656571889817
MECKEL SYNDROME 12; MKS12	0.00127551	0.11586656571889817
VERVERI-BRADY SYNDROME; VERBRAS	0.00127551	0.11586656571889817
MICROHYDRANENCEPHALY; MHAC	0.00127551	0.11586656571889817
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 2; CEMCOX2	0.00127551	0.11586656571889817
CHONDRODYSPLASIA-PSEUDOHERMAPHRODITISM SYNDROME	0.00127551	0.11586656571889817
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.00127551	0.11586656571889817
CHROMOSOME 1q21.1 DELETION SYNDROME, 1.35-MB	0.00127551	0.11586656571889817
#614673 MICROCEPHALY 8, PRIMARY, AUTOSOMAL RECESSIVE; MCPH8	0.00127551	0.11586656571889817
SPINAL MUSCULAR ATROPHY WITH MENTAL RETARDATION	0.00127551	0.11586656571889817
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.00127551	0.11586656571889817
MICROCEPHALY 24, PRIMARY, AUTOSOMAL RECESSIVE; MCPH24	0.00127551	0.11586656571889817
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.00127551	0.11586656571889817
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.00127551	0.11586656571889817
#227645 FANCONI ANEMIA, COMPLEMENTATION GROUP C; FANCC;;FACC; FAC;;FANCONI PANCYTOPENIA, TYPE 3; FA3	0.00127551	0.11586656571889817
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.00127551	0.11586656571889817
HYPERREFLEXIA	0.00127551	0.11586656571889817
207790 ARACHNOID CYSTS, INTRACRANIAL	0.00127551	0.11586656571889817
HYPOSPADIAS-MENTAL RETARDATION SYNDROME	0.00127551	0.11586656571889817
MICROCEPHALY, AUTOSOMAL DOMINANT	0.00127551	0.11586656571889817
MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA	0.00127551	0.11586656571889817
CHROMOSOME Xp11.3 DELETION SYNDROME	0.00127551	0.11586656571889817
VELOCARDIOFACIAL SYNDROME	0.00127551	0.11586656571889817
#613630 COCOON SYNDROME;;FETAL ENCASEMENT SYNDROME	0.00127551	0.11586656571889817
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.00127551	0.11586656571889817
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.00127551	0.11586656571889817
XFE PROGEROID SYNDROME; XFEPS	0.00127551	0.11586656571889817
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.00127551	0.11586656571889817
LARYNGEAL ABDUCTOR PARALYSIS	0.00127551	0.11586656571889817
MEIER-GORLIN SYNDROME 3; MGORS3	0.00127551	0.11586656571889817
RUVALCABA SYNDROME	0.00127551	0.11586656571889817
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.00127551	0.11586656571889817
RHIZOMELIC SYNDROME	0.00127551	0.11586656571889817
MICROPHTHALMIA, SYNDROMIC 1	0.00127551	0.11586656571889817
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.00127551	0.11586656571889817
YUNIS-VARON SYNDROME	0.00127551	0.11586656571889817
SECKEL SYNDROME 1; SCKL1	0.00127551	0.11586656571889817
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.00127551	0.11586656571889817
SECKEL SYNDROME 2; SCKL2	0.00127551	0.11586656571889817
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.00127551	0.11586656571889817
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.00127551	0.11586656571889817
MICROCEPHALY-CARDIOMYOPATHY	0.00127551	0.11586656571889817
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00127551	0.11586656571889817
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.00127551	0.11586656571889817
15q24 recurrent microdeletion syndrome	0.00127551	0.11586656571889817
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28	0.00127551	0.11586656571889817
#612390 PONTOCEREBELLAR HYPOPLASIA, TYPE 2C; PCH2C	0.00127551	0.11586656571889817
#615715 BONE MARROW FAILURE SYNDROME 2; BMFS2	0.00127551	0.11586656571889817
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.00127551	0.11586656571889817
%270750 SPASTIC PARAPLEGIA 23; SPG23;;SPASTIC PARAPLEGIA WITH PIGMENTARY ABNORMALITIES;;SPASTIC PARAPARESIS, VITILIGO, PREMATURE GRAYING, CHARACTERISTIC FACIES;;LISON SYNDROME	0.00127551	0.11586656571889817
BOWEN-CONRADI SYNDROME	0.00127551	0.11586656571889817
HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY	0.00127551	0.11586656571889817
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.00127551	0.11586656571889817
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.00127551	0.11586656571889817
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 50; MRT50	0.00127551	0.11586656571889817
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1	0.00127551	0.11586656571889817
MEIER-GORLIN SYNDROME 5; MGORS5	0.00127551	0.11586656571889817
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.00127551	0.11586656571889817
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.00127551	0.11586656571889817
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.00127551	0.11586656571889817
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.00127551	0.11586656571889817
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.00127551	0.11586656571889817
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.00127551	0.11586656571889817
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00127551	0.11586656571889817
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.00127551	0.11586656571889817
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.00127551	0.11586656571889817
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.00127551	0.11586656571889817
GERODERMA OSTEODYSPLASTICUM; GO	0.00127551	0.11586656571889817
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.00127551	0.11586656571889817
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.00127551	0.11586656571889817
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.00127551	0.11586656571889817
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.00127551	0.11586656571889817
601453 TRICHODENTAL DYSPLASIA	0.00127551	0.11586656571889817
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.00127551	0.11586656571889817
#300534 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE; MRXSCJ;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, JARID1C-RELATED; MRXSJ	0.00127551	0.11586656571889817
FANCONI ANEMIA, COMPLEMENTATION GROUP V	0.00127551	0.11586656571889817
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00127551	0.11586656571889817
MICROCEPHALY WITH CERVICAL SPINE FUSION ANOMALIES	0.00127551	0.11586656571889817
BRANCHIOOCULOFACIAL SYNDROME	0.00127551	0.11586656571889817
MENKES DISEASE	0.00127551	0.11586656571889817
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00127551	0.11586656571889817
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.00127551	0.11586656571889817
BARDET-BIEDL SYNDROME 20	0.00127551	0.11586656571889817
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.00127551	0.11586656571889817
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.00127551	0.11586656571889817
IMMUNODEFICIENCY 55; IMD55	0.00127551	0.11586656571889817
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00127551	0.11586656571889817
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.00127551	0.11586656571889817
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.00127551	0.11586656571889817
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.00127551	0.11586656571889817
ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES	0.00127551	0.11586656571889817
1q21.1 recurrent microdeletion (susceptibility locus for neurodevelopmental disorders)	0.00127551	0.11586656571889817
MEIER-GORLIN SYNDROME 6; MGORS6	0.00127551	0.11586656571889817
FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	0.00127551	0.11586656571889817
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00127551	0.11586656571889817
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.00127551	0.11586656571889817
MICROCEPHALY 23, PRIMARY, AUTOSOMAL RECESSIVE; MCPH23	0.00127551	0.11586656571889817
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.00127551	0.11586656571889817
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.00127551	0.11586656571889817
#613151 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION),TYPE B, 3; MDDGB3;;MUSCULAR DYSTROPHY, CONGENITAL, POMGNT1-RELATED	0.00127551	0.11586656571889817
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.00127551	0.11586656571889817
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.00127551	0.11586656571889817
PAINE SYNDROME	0.00127551	0.11586656571889817
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.00127551	0.11586656571889817
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.00127551	0.11586656571889817
FACIOCARDIOMELIC SYNDROME	0.00127551	0.11586656571889817
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.00127551	0.11586656571889817
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.00127551	0.11586656571889817
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.00127551	0.11586656571889817
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.00127551	0.11586656571889817
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.00127551	0.11586656571889817
#256520 NEU-LAXOVA SYNDROME; NLS	0.00127551	0.11586656571889817
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.00127551	0.11586656571889817
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.00127551	0.11586656571889817
PERRAULT SYNDROME 3	0.00127551	0.11586656571889817
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.00127551	0.11586656571889817
FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ	0.00127551	0.11586656571889817
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.00127551	0.11586656571889817
CYCLIC VOMITING SYNDROME	0.00127551	0.11586656571889817
TRIGLYCERIDE STORAGE DISEASE, TYPE I	0.00127551	0.11586656571889817
LAMBOTTE SYNDROME	0.00127551	0.11586656571889817
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.00127551	0.11586656571889817
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.00127551	0.11586656571889817
#602541 MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE; MDCMC;;MUSCULAR DYSTROPHY, CONGENITAL, WITH MITOCHONDRIAL STRUCTURAL ABNORMALITIES	0.00127551	0.11586656571889817
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.00127551	0.11586656571889817
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.00127551	0.11586656571889817
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.00127551	0.11586656571889817
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.00127551	0.11586656571889817
FOCAL DERMAL HYPOPLASIA; FDH	0.00127551	0.11586656571889817
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.00127551	0.11586656571889817
MICROPHTHALMIA, SYNDROMIC 8; MCOPS8	0.00127551	0.11586656571889817
3MC SYNDROME 1	0.00127551	0.11586656571889817
MICROCEPHALY 12, PRIMARY, AUTOSOMAL RECESSIVE; MCPH12	0.00127551	0.11586656571889817
Cri du Chat Syndrome (5p deletion)	0.00127551	0.11586656571889817
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI	0.00127551	0.11586656571889817
ALLAN-HERNDON-DUDLEY SYNDROME	0.00127551	0.11586656571889817
248760 MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS	0.00127551	0.11586656571889817
#615328 SHAHEEN SYNDROME; SHNS	0.00127551	0.11586656571889817
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 30	0.00127551	0.11586656571889817
#608233 HERMANSKY-PUDLAK SYNDROME 2; HPS2	0.00127551	0.11586656571889817
SECKEL SYNDROME 4	0.00127551	0.11586656571889817
ARTHROGRYPOSIS, DISTAL, TYPE 2E	0.00127551	0.11586656571889817
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.00127551	0.11586656571889817
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.00127551	0.11586656571889817
EPIPHYSEAL DYSPLASIA, MICROCEPHALY, AND NYSTAGMUS	0.00127551	0.11586656571889817
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.00127551	0.11586656571889817
DE SANCTIS-CACCHIONE SYNDROME	0.00127551	0.11586656571889817
PSEUDOTRISOMY 13 SYNDROME	0.00127551	0.11586656571889817
#612438 LEUKODYSTROPHY, HYPOMYELINATING, 6; HLD6;;LEUKODYSTROPHY, HYPOMYELINATING, WITH ATROPHY OF THE BASAL GANGLIAAND CEREBELLUM; HABC	0.00127551	0.11586656571889817
FANCONI ANEMIA	0.00127551	0.11586656571889817
#613150 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES), TYPE A, 2; MDDGA2;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMT2-RELATED	0.00127551	0.11586656571889817
GAUCHER DISEASE, PERINATAL LETHAL	0.00127551	0.11586656571889817
#267430 RENAL TUBULAR DYSGENESIS; RTD;;PRIMITIVE RENAL TUBULE SYNDROMERENAL TUBULAR DYSGENESIS WITH CHOANAL ATRESIA AND ATHELIA, INCLUDED	0.00127551	0.11586656571889817
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.00127551	0.11586656571889817
KERATOSIS FOLLICULARIS, DWARFISM, AND CEREBRAL ATROPHY	0.00127551	0.11586656571889817
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.00127551	0.11586656571889817
#611943 RIDDLE SYNDROME;;RADIOSENSITIVITY, IMMUNODEFICIENCY, DYSMORPHIC FEATURES, AND LEARNINGDIFFICULTIES	0.00127551	0.11586656571889817
BLOOM SYNDROME	0.00127551	0.11586656571889817
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.00127551	0.11586656571889817
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, cblX TYPE	0.00127551	0.11586656571889817
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00127551	0.11586656571889817
TEEBI-SHALTOUT SYNDROME; TBSH	0.00127551	0.11586656571889817
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.00127551	0.11586656571889817
INCONTINENTIA PIGMENTI; IP	0.00127551	0.11586656571889817
FILIPPI SYNDROME; FLPIS	0.00127551	0.11586656571889817
ENCEPHALOMALACIA, MULTILOCULAR	0.00127551	0.11586656571889817
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.00127551	0.11586656571889817
PONTOCEREBELLAR HYPOPLASIA, TYPE 12; PCH12	0.00127551	0.11586656571889817
Recurrent 16p12.1 microdeletion (neurodevelopmental susceptibility locus)	0.00127551	0.11586656571889817
#613885 MECKEL SYNDROME, TYPE 8; MKS8	0.00127551	0.11586656571889817
Myhre syndrome	0.00127551	0.11586656571889817
FANCONI ANEMIA, COMPLEMENTATION GROUP U	0.00127551	0.11586656571889817
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.00127551	0.11586656571889817
MENTAL RETARDATION, X-LINKED 63	0.00127551	0.11586656571889817
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.00127551	0.11586656571889817
#219100 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IA; ARCL1A;;ARCL1;;CUTIS LAXA, AUTOSOMAL RECESSIVE	0.00127551	0.11586656571889817
Miller-Dieker syndrome (MDS)	0.00127551	0.11586656571889817
AICARDI SYNDROME; AIC	0.00127551	0.11586656571889817
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.00127551	0.11586656571889817
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.00127551	0.11586656571889817
#227646 FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2;;FAD2;;FANCONI ANEMIA, COMPLEMENTATION GROUP D; FANCD; FACD;;FANCONI PANCYTOPENIA, TYPE 4; FA4	0.00127551	0.11586656571889817
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.00127551	0.11586656571889817
HOLOPROSENCEPHALY WITH FETAL AKINESIA/HYPOKINESIA SEQUENCE	0.00127551	0.11586656571889817
MEIER-GORLIN SYNDROME 2; MGORS2	0.00127551	0.11586656571889817
STROMME SYNDROME; STROMS	0.00127551	0.11586656571889817
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.00127551	0.11586656571889817
WARBURG MICRO SYNDROME 1	0.00127551	0.11586656571889817
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.00127551	0.11586656571889817
SECKEL SYNDROME 10; SCKL10	0.00127551	0.11586656571889817
NIJMEGEN BREAKAGE SYNDROME	0.00127551	0.11586656571889817
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.00127551	0.11586656571889817
ABSENT EYEBROWS AND EYELASHES WITH MENTAL RETARDATION	0.00127551	0.11586656571889817
133750 EXTRASYSTOLES, MULTIFORM VENTRICULAR, WITH SHORT STATURE, HYPERPIGMENTATIONAND MICROCEPHALY	0.00127551	0.11586656571889817
HALLERMANN-STREIFF SYNDROME; HSS	0.00127551	0.11586656571889817
MOWAT-WILSON SYNDROME; MOWS	0.00127551	0.11586656571889817
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.00127551	0.11586656571889817
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00127551	0.11586656571889817
608432 CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM	0.00127551	0.11586656571889817
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.00127551	0.11586656571889817
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa; CDG2A	0.00127551	0.11586656571889817
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.00127551	0.11586656571889817
LACTIC ACIDURIA DUE TO D-LACTIC ACID	0.00127551	0.11586656571889817
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.00127551	0.11586656571889817
CHARGE SYNDROME	0.00127551	0.11586656571889817
PHENYLKETONURIA	0.00127551	0.11586656571889817
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.00127551	0.11586656571889817
#613804 MEIER-GORLIN SYNDROME 4; MGORS4	0.00127551	0.11586656571889817
#609308 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 1; MDDGC1;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2K; LGMD2K	0.00127551	0.11586656571889817
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.00127551	0.11586656571889817
FEINGOLD SYNDROME 2; FGLDS2	0.00127551	0.11586656571889817
ACHALASIA-MICROCEPHALY SYNDROME	0.00127551	0.11586656571889817
Angelman syndrome (Type 1)	0.00127551	0.11586656571889817
SECKEL SYNDROME 7; SCKL7	0.00127551	0.11586656571889817
MENTAL RETARDATION, X-LINKED 102	0.00127551	0.11586656571889817
#616311 MENTAL RETARDATION, AUTOSOMAL DOMINANT 33; MRD33	0.00127551	0.11586656571889817
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.00127551	0.11586656571889817
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.00127551	0.11586656571889817
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.00127551	0.11586656571889817
SPINAL MUSCULAR ATROPHY WITH MICROCEPHALY AND MENTAL SUBNORMALITY	0.00127551	0.11586656571889817
#610185 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME2; CAMRQ2;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 2	0.000843882	0.07665773628744207
#613668 MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY	0.000843882	0.07665773628744207
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000843882	0.07665773628744207
#231050 GELEOPHYSIC DYSPLASIA 1; GPHYSD1	0.000843882	0.07665773628744207
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.000843882	0.07665773628744207
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.000843882	0.07665773628744207
PELGER-HUET ANOMALY; PHA	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.000843882	0.07665773628744207
#300894 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5; NBIA5;;BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION; BPAN;;STATIC ENCEPHALOPATHY OF CHILDHOOD WITH NEURODEGENERATION IN ADULTHOOD;SENDA	0.000843882	0.07665773628744207
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.000843882	0.07665773628744207
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000843882	0.07665773628744207
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.000843882	0.07665773628744207
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.000843882	0.07665773628744207
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.000843882	0.07665773628744207
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.000843882	0.07665773628744207
MENTAL RETARDATION, X-LINKED 90	0.000843882	0.07665773628744207
PALLISTER-HALL SYNDROME	0.000843882	0.07665773628744207
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.000843882	0.07665773628744207
JOUBERT SYNDROME 35; JBTS35	0.000843882	0.07665773628744207
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.000843882	0.07665773628744207
MENTAL RETARDATION, X-LINKED 41	0.000843882	0.07665773628744207
#610951 CEROID LIPOFUSCINOSIS, NEURONAL, 7; CLN7	0.000843882	0.07665773628744207
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.000843882	0.07665773628744207
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.000843882	0.07665773628744207
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.000843882	0.07665773628744207
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.000843882	0.07665773628744207
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.000843882	0.07665773628744207
Pontine tegmental cap dysplasia	0.000843882	0.07665773628744207
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.000843882	0.07665773628744207
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000843882	0.07665773628744207
CRANIOTELENCEPHALIC DYSPLASIA	0.000843882	0.07665773628744207
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000843882	0.07665773628744207
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.000843882	0.07665773628744207
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.000843882	0.07665773628744207
#275900 SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE; SPG20;;TROYER SYNDROME;;SPASTIC PARAPARESIS, CHILDHOOD-ONSET, WITH DISTAL MUSCLE WASTING;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, TROYER TYPE	0.000843882	0.07665773628744207
ARIMA SYNDROME	0.000843882	0.07665773628744207
#600638 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULARINVOLVEMENT; CFEOM3A;;FEOM3 LOCUS	0.000843882	0.07665773628744207
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.000843882	0.07665773628744207
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.000843882	0.07665773628744207
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.000843882	0.07665773628744207
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.000843882	0.07665773628744207
MECKEL SYNDROME 13; MKS13	0.000843882	0.07665773628744207
NOONAN SYNDROME 11; NS11	0.000843882	0.07665773628744207
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.000843882	0.07665773628744207
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.000843882	0.07665773628744207
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.000843882	0.07665773628744207
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.000843882	0.07665773628744207
OROFACIODIGITAL SYNDROME XVI; OFD16	0.000843882	0.07665773628744207
PELLAGRA-LIKE SYNDROME	0.000843882	0.07665773628744207
HYPERTRYPTOPHANEMIA; HYPTRP	0.000843882	0.07665773628744207
#615665 JOUBERT SYNDROME 22; JBTS22	0.000843882	0.07665773628744207
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.000843882	0.07665773628744207
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.000843882	0.07665773628744207
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.000843882	0.07665773628744207
#300653 PHOSPHOGLYCERATE KINASE 1 DEFICIENCY;;PGK1 DEFICIENCY	0.000843882	0.07665773628744207
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000843882	0.07665773628744207
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000843882	0.07665773628744207
PRADER-WILLI SYNDROME; PWS	0.000843882	0.07665773628744207
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.000843882	0.07665773628744207
#225750 AICARDI-GOUTIERES SYNDROME 1; AGS1;;AGS;;ENCEPHALOPATHY, FAMILIAL INFANTILE, WITH INTRACRANIAL CALCIFICATIONAND CHRONIC CEREBROSPINAL FLUID LYMPHOCYTOSIS;;CREE ENCEPHALITIS;;PSEUDOTOXOPLASMOSIS SYNDROMEAICARDI-GOUTIERES SYNDROME 1, AUTOSOMAL DOMINANT, INCLUDED	0.000843882	0.07665773628744207
#615401 IMMUNODEFICIENCY 8; IMD8	0.000843882	0.07665773628744207
RITSCHER-SCHINZEL SYNDROME 1	0.000843882	0.07665773628744207
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.000843882	0.07665773628744207
JOUBERT SYNDROME 33; JBTS33	0.000843882	0.07665773628744207
Muenke syndrome	0.000843882	0.07665773628744207
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.000843882	0.07665773628744207
#222448 DONNAI-BARROW SYNDROME;;FACIOOCULOACOUSTICORENAL SYNDROME;;DBS/FOAR SYNDROME;;DIAPHRAGMATIC HERNIA, EXOMPHALOS, ABSENT CORPUS CALLOSUM, HYPERTELORISM,MYOPIA, SENSORINEURAL DEAFNESS, AND PROTEINURIA	0.000843882	0.07665773628744207
RICHARDS-RUNDLE SYNDROME; RRNS	0.000843882	0.07665773628744207
#608804 LEUKODYSTROPHY, HYPOMYELINATING, 2; HLD2;;PELIZAEUS-MERZBACHER-LIKE DISEASE, 1; PMLD1	0.000843882	0.07665773628744207
WEBB-DATTANI SYNDROME; WEDAS	0.000843882	0.07665773628744207
#610168 LOEYS-DIETZ SYNDROME 2; LDS2;;AORTIC ANEURYSM, FAMILIAL THORACIC 3; AAT3;;MARFAN SYNDROME, TYPE II, FORMERLY	0.000843882	0.07665773628744207
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.000843882	0.07665773628744207
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.000843882	0.07665773628744207
Jawad syndrome	0.000843882	0.07665773628744207
CURRY-JONES SYNDROME	0.000843882	0.07665773628744207
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000843882	0.07665773628744207
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.000843882	0.07665773628744207
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.000843882	0.07665773628744207
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000843882	0.07665773628744207
RAHMAN SYNDROME	0.000843882	0.07665773628744207
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.000843882	0.07665773628744207
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000843882	0.07665773628744207
#301835 ARTS SYNDROME; ARTS;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARTS TYPE; MRXSARTS;;ATAXIA, FATAL X-LINKED, WITH DEAFNESS AND LOSS OF VISION;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 18; MRXS18	0.000843882	0.07665773628744207
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000843882	0.07665773628744207
MELANOSIS, NEUROCUTANEOUS; NCMS	0.000843882	0.07665773628744207
#608027 PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3;;CEREBELLAR ATROPHY WITH PROGRESSIVE MICROCEPHALY; CLAM;;PCH WITH OPTIC ATROPHY	0.000843882	0.07665773628744207
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.000843882	0.07665773628744207
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.000843882	0.07665773628744207
BAND HETEROTOPIA; BH	0.000843882	0.07665773628744207
CHROMOSOME 22q11.2 DELETION SYNDROME, DISTAL	0.000843882	0.07665773628744207
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.000843882	0.07665773628744207
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000843882	0.07665773628744207
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000843882	0.07665773628744207
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000843882	0.07665773628744207
#608443 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 3; MRT3	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.000843882	0.07665773628744207
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.000843882	0.07665773628744207
KETOADIPICACIDURIA	0.000843882	0.07665773628744207
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.000843882	0.07665773628744207
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000843882	0.07665773628744207
#614202 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15; MRT15	0.000843882	0.07665773628744207
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.000843882	0.07665773628744207
CHROMOSOME 15q25 DELETION SYNDROME	0.000843882	0.07665773628744207
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.000843882	0.07665773628744207
#300848 MENTAL RETARDATION, X-LINKED 89; MRX89	0.000843882	0.07665773628744207
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.000843882	0.07665773628744207
CDAGS SYNDROME	0.000843882	0.07665773628744207
#607694 LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/ORHYPOGONADOTROPIC HYPOGONADISM; HLD7;;LEUKOENCEPHALOPATHY, HYPOMYELINATING, WITH ATAXIA AND DELAYED DENTITION;;ATAXIA, DELAYED DENTITION, AND HYPOMYELINATION; ADDH;;LEUKODYSTROPHY, HYPOMYELINATING, WITH HYPODONTIA AND HYPOGONADOTROPICHYPOGONADISM;;4H SYNDROME	0.000843882	0.07665773628744207
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.000843882	0.07665773628744207
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.000843882	0.07665773628744207
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000843882	0.07665773628744207
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.000843882	0.07665773628744207
#614732 INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIACONGENITA, AND GENITAL ANOMALIES;;IMAGE SYNDROME	0.000843882	0.07665773628744207
BARDET-BIEDL SYNDROME 3; BBS3	0.000843882	0.07665773628744207
#300123 MENTAL RETARDATION, X-LINKED, WITH PANHYPOPITUITARISMMENTAL RETARDATION, X-LINKED, WITH ISOLATED GROWTH HORMONE DEFICIENCY,INCLUDED; MRGH, INCLUDED	0.000843882	0.07665773628744207
NIEMANN-PICK DISEASE, TYPE A	0.000843882	0.07665773628744207
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.000843882	0.07665773628744207
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000843882	0.07665773628744207
NIEMANN-PICK DISEASE, TYPE C2	0.000843882	0.07665773628744207
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.000843882	0.07665773628744207
#300895 OHDO SYNDROME, X-LINKED; OHDOX;;BLEPHAROPHIMOSIS-MENTAL RETARDATION SYNDROME, MAAT-KIEVIT-BRUNNERTYPE	0.000843882	0.07665773628744207
#218000 AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY; ACCPN;;CHARLEVOIX DISEASE;;ANDERMANN SYNDROME;;POLYNEUROPATHY, SENSORIMOTOR, WITH OR WITHOUT AGENESIS OF THE CORPUSCALLOSUM;;CORPUS CALLOSUM, AGENESIS OF, WITH NEURONOPATHY	0.000843882	0.07665773628744207
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.000843882	0.07665773628744207
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.000843882	0.07665773628744207
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.000843882	0.07665773628744207
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.000843882	0.07665773628744207
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.000843882	0.07665773628744207
MENTAL RETARDATION, X-LINKED 9	0.000843882	0.07665773628744207
JOUBERT SYNDROME 2	0.000843882	0.07665773628744207
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.000843882	0.07665773628744207
SCHAAF-YANG SYNDROME; SHFYNG	0.000843882	0.07665773628744207
Retinitis pigmentosa with or without skeletal anomalies	0.000843882	0.07665773628744207
#300422 FG SYNDROME 4; FGS4MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT NYSTAGMUS, INCLUDED	0.000843882	0.07665773628744207
CHROMOSOME 22q13 DUPLICATION SYNDROME	0.000843882	0.07665773628744207
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.000843882	0.07665773628744207
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000843882	0.07665773628744207
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.000843882	0.07665773628744207
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.000843882	0.07665773628744207
BARDET-BIEDL SYNDROME 1; BBS1	0.000843882	0.07665773628744207
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.000843882	0.07665773628744207
BARDET-BIEDL SYNDROME 16; BBS16	0.000843882	0.07665773628744207
JOUBERT SYNDROME 6	0.000843882	0.07665773628744207
COFFIN-SIRIS SYNDROME 2; CSS2	0.000843882	0.07665773628744207
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.000843882	0.07665773628744207
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu; CDG1U	0.000843882	0.07665773628744207
PHACE ASSOCIATION	0.000843882	0.07665773628744207
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.000843882	0.07665773628744207
#603387 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME;MPPH;;MEGALENCEPHALY, POLYMICROGYRIA, MEGA CORPUS CALLOSUM SYNDROME;;MEG-PMG-MEGACC SYNDROME;;MEGALENCEPHALY, MEGA CORPUS CALLOSUM, AND COMPLETE LACK OF MOTOR DEVELOPMENT	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000843882	0.07665773628744207
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.000843882	0.07665773628744207
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.000843882	0.07665773628744207
STEEL SYNDROME; STLS	0.000843882	0.07665773628744207
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000843882	0.07665773628744207
#300673 ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS	0.000843882	0.07665773628744207
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.000843882	0.07665773628744207
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.000843882	0.07665773628744207
MENTAL RETARDATION, X-LINKED 103	0.000843882	0.07665773628744207
SWEENEY-COX SYNDROME; SWCOS	0.000843882	0.07665773628744207
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.000843882	0.07665773628744207
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.000843882	0.07665773628744207
BARDET-BIEDL SYNDROME 17; BBS17	0.000843882	0.07665773628744207
CHROMOSOME 15Q14 DELETION SYNDROME	0.000843882	0.07665773628744207
CHROMOSOME 10q22.3-q23.2 DELETION SYNDROME	0.000843882	0.07665773628744207
#117550 SOTOS SYNDROME 1; SOTOS1;;SOTOS SYNDROME;;CEREBRAL GIGANTISM;;CHROMOSOME 5q35 DELETION SYNDROME	0.000843882	0.07665773628744207
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.000843882	0.07665773628744207
#612714 EXOCRINE PANCREATIC INSUFFICIENCY, DYSERYTHROPOIETIC ANEMIA, AND CALVARIALHYPEROSTOSIS	0.000843882	0.07665773628744207
#615278 CARDIOFACIOCUTANEOUS SYNDROME 2; CFC2	0.000843882	0.07665773628744207
#609054 FANCONI ANEMIA, COMPLEMENTATION GROUP J; FANCJ	0.000843882	0.07665773628744207
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.000843882	0.07665773628744207
#272200 MULTIPLE SULFATASE DEFICIENCY; MSD;;MUCOSULFATIDOSIS;;SULFATIDOSIS, JUVENILE, AUSTIN TYPE	0.000843882	0.07665773628744207
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000843882	0.07665773628744207
GAUCHER DISEASE, TYPE II	0.000843882	0.07665773628744207
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000843882	0.07665773628744207
MEIER-GORLIN SYNDROME 7	0.000843882	0.07665773628744207
JOUBERT SYNDROME 23; JBTS23	0.000843882	0.07665773628744207
RECOMBINANT CHROMOSOME 8 SYNDROME	0.000843882	0.07665773628744207
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.000843882	0.07665773628744207
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.000843882	0.07665773628744207
TIMOTHY SYNDROME; TS	0.000843882	0.07665773628744207
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.000843882	0.07665773628744207
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.000843882	0.07665773628744207
BARDET-BIEDL SYNDROME 13; BBS13	0.000843882	0.07665773628744207
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000843882	0.07665773628744207
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000843882	0.07665773628744207
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii; CDG1I	0.000843882	0.07665773628744207
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.000843882	0.07665773628744207
SEPTOOPTIC DYSPLASIA	0.000843882	0.07665773628744207
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000843882	0.07665773628744207
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000843882	0.07665773628744207
CHROMOSOME 16p13.2 DELETION SYNDROME	0.000843882	0.07665773628744207
ROSSELLI-GULIENETTI SYNDROME	0.000843882	0.07665773628744207
JOUBERT SYNDROME 8	0.000843882	0.07665773628744207
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.000843882	0.07665773628744207
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.000843882	0.07665773628744207
Cerebral creatine deficiency syndrome 2	0.000843882	0.07665773628744207
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.000843882	0.07665773628744207
CRANIOFRONTONASAL SYNDROME; CFNS	0.000843882	0.07665773628744207
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.000843882	0.07665773628744207
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.000843882	0.07665773628744207
CHROMOSOME 4q21 DELETION SYNDROME	0.000843882	0.07665773628744207
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.000843882	0.07665773628744207
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.000843882	0.07665773628744207
#268310 ROBINOW SYNDROME, AUTOSOMAL RECESSIVE; RRS;;COSTOVERTEBRAL SEGMENTATION DEFECT WITH MESOMELIA, FORMERLY;;COVESDEM SYNDROME, FORMERLYROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH APLASIA/HYPOPLASIA OFPHALANGES AND METACARPALS/METATARSALS, INCLUDED;;ROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH BRACHY-SYN-POLYDACTYLY,INCLUDED	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.000843882	0.07665773628744207
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.000843882	0.07665773628744207
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.000843882	0.07665773628744207
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000843882	0.07665773628744207
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.000843882	0.07665773628744207
OROTIC ACIDURIA	0.000843882	0.07665773628744207
SHUKLA-VERNON SYNDROME; SHUVER	0.000843882	0.07665773628744207
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.000843882	0.07665773628744207
#614873 PEROXISOME BIOGENESIS DISORDER 7B; PBD7B	0.000843882	0.07665773628744207
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000843882	0.07665773628744207
#614845 NEPHRONOPHTHISIS 15; NPHP15	0.000843882	0.07665773628744207
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000843882	0.07665773628744207
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.000843882	0.07665773628744207
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.000843882	0.07665773628744207
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.000843882	0.07665773628744207
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.000843882	0.07665773628744207
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000843882	0.07665773628744207
RETINITIS PIGMENTOSA 80; RP80	0.000843882	0.07665773628744207
PEROXISOME BIOGENESIS DISORDER 3B	0.000843882	0.07665773628744207
#615473 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 17; EIEE17	0.000843882	0.07665773628744207
SENIOR-LOKEN SYNDROME 9	0.000843882	0.07665773628744207
IMMUNODEFICIENCY 49; IMD49	0.000843882	0.07665773628744207
GABA-TRANSAMINASE DEFICIENCY	0.000843882	0.07665773628744207
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.000843882	0.07665773628744207
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.000843882	0.07665773628744207
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.000843882	0.07665773628744207
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.000843882	0.07665773628744207
DIAMOND-BLACKFAN ANEMIA 5	0.000843882	0.07665773628744207
GM2-GANGLIOSIDOSIS, AB VARIANT	0.000843882	0.07665773628744207
COFFIN-SIRIS SYNDROME 7; CSS7	0.000843882	0.07665773628744207
ANGELMAN SYNDROME	0.000843882	0.07665773628744207
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.000843882	0.07665773628744207
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.000843882	0.07665773628744207
LANDAU-KLEFFNER SYNDROME	0.000843882	0.07665773628744207
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.000843882	0.07665773628744207
HURLER SYNDROME	0.000843882	0.07665773628744207
#615314 CRANIOSYNOSTOSIS 3; CRS3	0.000843882	0.07665773628744207
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.000843882	0.07665773628744207
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.000843882	0.07665773628744207
PEROXISOME BIOGENESIS DISORDER 5B	0.000843882	0.07665773628744207
#300555 DENT DISEASE 2	0.000843882	0.07665773628744207
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.000843882	0.07665773628744207
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.000843882	0.07665773628744207
#607208 DRAVET SYNDROME;;EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 6; EIEE6;;SEVERE MYOCLONIC EPILEPSY OF INFANCY; SMEI	0.000843882	0.07665773628744207
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000843882	0.07665773628744207
CHOPS SYNDROME; CHOPS	0.000843882	0.07665773628744207
JOUBERT SYNDROME 7	0.000843882	0.07665773628744207
#615432 SPECIFIC LANGUAGE IMPAIRMENT 5; SLI5	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.000843882	0.07665773628744207
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.000843882	0.07665773628744207
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.000843882	0.07665773628744207
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000843882	0.07665773628744207
300270 ADRENOMYODYSTROPHY	0.000843882	0.07665773628744207
SHASHI-PENA SYNDROME; SHAPNS	0.000843882	0.07665773628744207
#615279 CARDIOFACIOCUTANEOUS SYNDROME 3; CFC3	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.000843882	0.07665773628744207
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.000843882	0.07665773628744207
DIGEORGE SYNDROME; DGS	0.000843882	0.07665773628744207
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.000843882	0.07665773628744207
GABRIELE-DE VRIES SYNDROME; GADEVS	0.000843882	0.07665773628744207
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.000843882	0.07665773628744207
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000843882	0.07665773628744207
#613076 MYOPATHY, MITOCHONDRIAL PROGRESSIVE, WITH CONGENITAL CATARACT, HEARINGLOSS, AND DEVELOPMENTAL DELAY;;MYOPATHY WITH CATARACT AND COMBINED RESPIRATORY CHAIN DEFICIENCY;;MITOCHONDRIAL COMPLEX DEFICIENCY, COMBINED	0.000843882	0.07665773628744207
#136570 CHROMOSOME 16p12.1 DELETION SYNDROME, 520-KBFRAGILE SITE 16p12, INCLUDED	0.000843882	0.07665773628744207
JOUBERT SYNDROME 25	0.000843882	0.07665773628744207
#613641 CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE B; CMTRIB;;CHARCOT-MARIE-TOOTH NEUROPATHY, RECESSIVE INTERMEDIATE B; RI-CMTB	0.000843882	0.07665773628744207
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.000843882	0.07665773628744207
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000843882	0.07665773628744207
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.000843882	0.07665773628744207
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.000843882	0.07665773628744207
#300868 MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2; MCAHS2	0.000843882	0.07665773628744207
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.000843882	0.07665773628744207
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.000843882	0.07665773628744207
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.000843882	0.07665773628744207
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.000843882	0.07665773628744207
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.000843882	0.07665773628744207
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000843882	0.07665773628744207
JOUBERT SYNDROME 31; JBTS31	0.000843882	0.07665773628744207
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000843882	0.07665773628744207
#616341 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 30; EIEE30	0.000843882	0.07665773628744207
NOONAN SYNDROME 2; NS2	0.000843882	0.07665773628744207
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000843882	0.07665773628744207
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000843882	0.07665773628744207
SULFOCYSTEINURIA	0.000843882	0.07665773628744207
JOUBERT SYNDROME 28	0.000843882	0.07665773628744207
#614483 PORENCEPHALY 2; POREN2	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.000843882	0.07665773628744207
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.000843882	0.07665773628744207
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000843882	0.07665773628744207
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.000843882	0.07665773628744207
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.000843882	0.07665773628744207
GALACTOSE EPIMERASE DEFICIENCY	0.000843882	0.07665773628744207
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.000843882	0.07665773628744207
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.000843882	0.07665773628744207
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.000843882	0.07665773628744207
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000843882	0.07665773628744207
FOLATE MALABSORPTION, HEREDITARY	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.000843882	0.07665773628744207
FRIAS SYNDROME	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000843882	0.07665773628744207
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.000843882	0.07665773628744207
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIq; CDG2Q	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.000843882	0.07665773628744207
JOUBERT SYNDROME 27	0.000843882	0.07665773628744207
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.000843882	0.07665773628744207
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000843882	0.07665773628744207
PEROXISOME BIOGENESIS DISORDER 10B	0.000843882	0.07665773628744207
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000843882	0.07665773628744207
WAARDENBURG-SHAH SYNDROME	0.000843882	0.07665773628744207
611961 STEVENSON-CAREY SYNDROME	0.000843882	0.07665773628744207
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIg; CDG2G	0.000843882	0.07665773628744207
MIRAGE SYNDROME; MIRAGE	0.000843882	0.07665773628744207
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.000843882	0.07665773628744207
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.000843882	0.07665773628744207
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.000843882	0.07665773628744207
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000843882	0.07665773628744207
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.000843882	0.07665773628744207
MENTAL RETARDATION, X-LINKED 72	0.000843882	0.07665773628744207
TEMTAMY SYNDROME; TEMTYS	0.000843882	0.07665773628744207
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.000843882	0.07665773628744207
CHROMOSOME 2q37 DELETION SYNDROME	0.000843882	0.07665773628744207
WAISMAN SYNDROME; WSMN	0.000843882	0.07665773628744207
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.000843882	0.07665773628744207
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.000843882	0.07665773628744207
IMMUNODEFICIENCY 23; IMD23	0.000843882	0.07665773628744207
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000843882	0.07665773628744207
MEND SYNDROME; MEND	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.000843882	0.07665773628744207
Bardet-Biedl syndrome 2	0.000843882	0.07665773628744207
#607454 SPINOCEREBELLAR ATAXIA 21; SCA21	0.000843882	0.07665773628744207
MENTAL RETARDATION, X-LINKED 101; MRX101	0.000843882	0.07665773628744207
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.000843882	0.07665773628744207
ELEJALDE DISEASE	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000843882	0.07665773628744207
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000843882	0.07665773628744207
KAGAMI-OGATA SYNDROME	0.000843882	0.07665773628744207
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.000843882	0.07665773628744207
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.000843882	0.07665773628744207
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.000843882	0.07665773628744207
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.000843882	0.07665773628744207
ROIFMAN-CHITAYAT SYNDROME	0.000843882	0.07665773628744207
COACH SYNDROME	0.000843882	0.07665773628744207
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.000843882	0.07665773628744207
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000843882	0.07665773628744207
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.000843882	0.07665773628744207
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.000843882	0.07665773628744207
#615280 CARDIOFACIOCUTANEOUS SYNDROME 4; CFC4	0.000843882	0.07665773628744207
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000843882	0.07665773628744207
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.000843882	0.07665773628744207
#615220 OSTEOGENESIS IMPERFECTA, TYPE XV; OI15;;OI, TYPE XV	0.000843882	0.07665773628744207
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.000843882	0.07665773628744207
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000843882	0.07665773628744207
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.000843882	0.07665773628744207
CURRARINO SYNDROME	0.000843882	0.07665773628744207
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.000843882	0.07665773628744207
3MC SYNDROME 2	0.000843882	0.07665773628744207
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.000843882	0.07665773628744207
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.000843882	0.07665773628744207
#303110 CHOROIDEREMIA, DEAFNESS, AND MENTAL RETARDATION;;CHROMOSOME Xq21 DELETION SYNDROME	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.000843882	0.07665773628744207
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.000843882	0.07665773628744207
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.000843882	0.07665773628744207
HYPEREKPLEXIA 4; HKPX4	0.000843882	0.07665773628744207
TARP SYNDROME; TARPS	0.000843882	0.07665773628744207
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000843882	0.07665773628744207
CHROMOSOME 19q13.11 DELETION SYNDROME, PROXIMAL	0.000843882	0.07665773628744207
MENTAL RETARDATION, X-LINKED 88	0.000843882	0.07665773628744207
#300886 MENTAL RETARDATION, X-LINKED, SYNDROMIC 32; MRXS32	0.000843882	0.07665773628744207
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000843882	0.07665773628744207
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.000843882	0.07665773628744207
#610915 OSTEOGENESIS IMPERFECTA, TYPE VIII; OI8;;OI, TYPE VIII	0.000843882	0.07665773628744207
SAUL-WILSON SYNDROME; SWILS	0.000843882	0.07665773628744207
#613657 D-2-@HYDROXYGLUTARIC ACIDURIA 2;;D2HGA2	0.000843882	0.07665773628744207
CHROMOSOME 16p11.2 DELETION SYNDROME, 593-KB	0.000843882	0.07665773628744207
MACROCEPHALY/AUTISM SYNDROME	0.000843882	0.07665773628744207
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.000843882	0.07665773628744207
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.000843882	0.07665773628744207
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.000843882	0.07665773628744207
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.000843882	0.07665773628744207
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000843882	0.07665773628744207
#614402 MICROPHTHALMIA, SYNDROMIC 11; MCOPS11	0.000843882	0.07665773628744207
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000843882	0.07665773628744207
HOLOPROSENCEPHALY 7	0.000843882	0.07665773628744207
JOUBERT SYNDROME 21	0.000843882	0.07665773628744207
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.000843882	0.07665773628744207
HARTNUP DISORDER	0.000843882	0.07665773628744207
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.000843882	0.07665773628744207
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.000843882	0.07665773628744207
AUSTRALIA ANTIGEN	0.000843882	0.07665773628744207
Cerebral creatine deficiency syndrome 3	0.000843882	0.07665773628744207
JOUBERT SYNDROME 30; JBTS30	0.000843882	0.07665773628744207
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.000843882	0.07665773628744207
GRACILE BONE DYSPLASIA; GCLEB	0.000843882	0.07665773628744207
ALSTROM SYNDROME; ALMS	0.000843882	0.07665773628744207
HYPERPROLINEMIA, TYPE I	0.000843882	0.07665773628744207
JOUBERT SYNDROME 15	0.000843882	0.07665773628744207
BARDET-BIEDL SYNDROME 14; BBS14	0.000843882	0.07665773628744207
NOONAN SYNDROME 9; NS9	0.000843882	0.07665773628744207
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.000843882	0.07665773628744207
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000843882	0.07665773628744207
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.000843882	0.07665773628744207
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.000843882	0.07665773628744207
Helsmoortel-van der Aa syndrome	0.000843882	0.07665773628744207
MENTAL RETARDATION, X-LINKED 99	0.000843882	0.07665773628744207
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.000843882	0.07665773628744207
JOUBERT SYNDROME 26	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000843882	0.07665773628744207
POPOV-CHANG SYNDROME; POPCHAS	0.000843882	0.07665773628744207
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.000843882	0.07665773628744207
#611718 HYPOMAGNESEMIA 4, RENAL; HOMG4;;HYPOMAGNESEMIA, RENAL, NORMOCALCIURIC	0.000843882	0.07665773628744207
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.000843882	0.07665773628744207
JOUBERT SYNDROME 32; JBTS32	0.000843882	0.07665773628744207
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.000843882	0.07665773628744207
#609528 CEREBRAL DYSGENESIS, NEUROPATHY, ICHTHYOSIS, AND PALMOPLANTAR KERATODERMASYNDROME;;CEDNIK SYNDROME	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.000843882	0.07665773628744207
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.000843882	0.07665773628744207
CREE MENTAL RETARDATION SYNDROME	0.000843882	0.07665773628744207
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.000843882	0.07665773628744207
#121200 SEIZURES, BENIGN FAMILIAL NEONATAL, 1; BFNS1EPILEPSY, BENIGN NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED;;SEIZURES, BENIGN FAMILIAL NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED	0.000843882	0.07665773628744207
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.000843882	0.07665773628744207
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.000843882	0.07665773628744207
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000843882	0.07665773628744207
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.000843882	0.07665773628744207
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.000843882	0.07665773628744207
HAREL-YOON SYNDROME; HAYOS	0.000843882	0.07665773628744207
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000843882	0.07665773628744207
#615033 SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE; SPG54	0.000843882	0.07665773628744207
MENTAL RETARDATION, X-LINKED 104; MRX104	0.000843882	0.07665773628744207
CULLER-JONES SYNDROME; CJS	0.000843882	0.07665773628744207
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.000843882	0.07665773628744207
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.000843882	0.07665773628744207
XIA-GIBBS SYNDROME	0.000843882	0.07665773628744207
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.000843882	0.07665773628744207
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000843882	0.07665773628744207
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.000843882	0.07665773628744207
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000843882	0.07665773628744207
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.000843882	0.07665773628744207
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.000843882	0.07665773628744207
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.000843882	0.07665773628744207
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.000843882	0.07665773628744207
#613752 HYPERMETHIONINEMIA WITH S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.000843882	0.07665773628744207
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.000843882	0.07665773628744207
#614213 NEUROPATHY, HEREDITARY SENSORY, TYPE IIC; HSN2C	0.000843882	0.07665773628744207
JOUBERT SYNDROME 17; JBTS17	0.000843882	0.07665773628744207
GRISCELLI SYNDROME, TYPE 1	0.000843882	0.07665773628744207
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.000843882	0.07665773628744207
#274000 THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME; TAR;;TAR SYNDROME;;CHROMOSOME 1q21.1 DELETION SYNDROME, 200-KB	0.000843882	0.07665773628744207
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.000843882	0.07665773628744207
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.000843882	0.07665773628744207
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000843882	0.07665773628744207
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.000843882	0.07665773628744207
THANATOPHORIC DYSPLASIA, TYPE I	0.000843882	0.07665773628744207
CHROMOSOME Xq27.3-q28 DUPLICATION SYNDROME	0.000843882	0.07665773628744207
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000843882	0.07665773628744207
CHAR SYNDROME	0.000843882	0.07665773628744207
NEPHRONOPHTHISIS 11; NPHP11	0.000843882	0.07665773628744207
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.000843882	0.07665773628744207
CHROMOSOME 18P DELETION SYNDROME	0.000843882	0.07665773628744207
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.000843882	0.07665773628744207
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.000843882	0.07665773628744207
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic; CDG1C	0.000843882	0.07665773628744207
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.000843882	0.07665773628744207
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.000843882	0.07665773628744207
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.000843882	0.07665773628744207
#613721 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 11; EIEE11	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.000843882	0.07665773628744207
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000843882	0.07665773628744207
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.000843882	0.07665773628744207
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.000843882	0.07665773628744207
CATEL-MANZKE SYNDROME; CATMANS	0.000843882	0.07665773628744207
Aarskog-Scott syndrome	0.000843882	0.07665773628744207
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.000843882	0.07665773628744207
#207800 ARGININEMIA;;ARGINASE DEFICIENCY;;HYPERARGININEMIA;;ARG1 DEFICIENCY	0.000843882	0.07665773628744207
LUSCAN-LUMISH SYNDROME; LLS	0.000843882	0.07665773628744207
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.000843882	0.07665773628744207
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000843882	0.07665773628744207
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000843882	0.07665773628744207
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.000843882	0.07665773628744207
BARDET-BIEDL SYNDROME 8; BBS8	0.000843882	0.07665773628744207
RAYNAUD-CLAES SYNDROME; MRXSRC	0.000843882	0.07665773628744207
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.000843882	0.07665773628744207
CODAS SYNDROME	0.000843882	0.07665773628744207
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.000843882	0.07665773628744207
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig; CDG1G	0.000843882	0.07665773628744207
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.000843882	0.07665773628744207
AU-KLINE SYNDROME; AUKS	0.000843882	0.07665773628744207
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000843882	0.07665773628744207
#615066 OSTEOGENESIS IMPERFECTA, TYPE XIV; OI14 ;;OI, TYPE XIV	0.000843882	0.07665773628744207
#300257 DANON DISEASE;;VACUOLAR CARDIOMYOPATHY AND MYOPATHY, X-LINKED;;PSEUDOGLYCOGENOSIS II;;ANTOPOL DISEASE;;LYSOSOMAL GLYCOGEN STORAGE DISEASE WITHOUT ACID MALTASE DEFICIENCY,FORMERLY;;GLYCOGEN STORAGE DISEASE IIb; GSD2B, FORMERLY;;GSD IIb, FORMERLY	0.000843882	0.07665773628744207
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000843882	0.07665773628744207
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.000843882	0.07665773628744207
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.000843882	0.07665773628744207
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.000843882	0.07665773628744207
#613730 HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION,AND CATARACTS; HDBSCC	0.000843882	0.07665773628744207
MENTAL RETARDATION, X-LINKED 98; MRX98	0.000843882	0.07665773628744207
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.000843882	0.07665773628744207
LISSENCEPHALY 1; LIS1	0.000843882	0.07665773628744207
PEROXISOME BIOGENESIS DISORDER 6B	0.000843882	0.07665773628744207
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.000843882	0.07665773628744207
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.000843882	0.07665773628744207
ARGININOSUCCINIC ACIDURIA	0.000843882	0.07665773628744207
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.000843882	0.07665773628744207
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.000843882	0.07665773628744207
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.000843882	0.07665773628744207
#614970 JOUBERT SYNDROME 20; JBTS20	0.000843882	0.07665773628744207
